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ABSTRACT
Macrophages infected with a heavy burden of M.tb Erdman undergo a cell 
death that initially resembles apoptosis but quickly transitions to necrosis.  Unlike 
the previously reported TNF dependent apoptosis induced by avirulent 
Mycobacterium [1], this form of macrophage cell death is not microbicidal [2].  
Microbicidal effects are observed however, when the heavily infected 
macrophage encounters an uninfected naïve macrophage.  My studies describe 
in part, the crosstalk between the uninfected and infected macrophage that 
results in the killing of the intracellular M.tb.  Cell contact between the two cell 
populations is not necessary for this killing of bacilli to occur and the soluble 
“signal” of communication between the two cell populations is transferrable, 
without naïve macrophages present, to newly infected cells also resulting in the 
reduced viability of the bacilli.  We have found that when the IL-1 receptor is 
absent in the naïve macrophage population that the co-culture antimycobacterial 
effect is abrogated, suggesting that IL-1 released by the infected dying 
macrophage is critical for naïve macrophages to respond in a way that results in 
the decrease in mycobacterial viability.  The signaling between the two cell 
population ultimately converges on activation of iNOS in the infected cell 
however ROS appears not to be involved.  
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CHAPTER I: Introduction
The TB Pandemic
 Tuberculosis (TB) is one of the highest infectious killer of adults worldwide, 
only second to human immunodeficiency virus (HIV) killing 1.3 million people in 
2009 (WHO, 2010).  Approximately one third of the world’s population is 
estimated to have latent infection and around 9 million new cases are reported 
annually.    Though many people with TB will never suffer from clinical disease, 
5-10% of patients will suffer from active TB and around 13 million people suffer 
from active disease globally at any one time.  TB has an economic impact of 
between $1-3 trillion dollars annually and is most prevalent in some of the world’s  
poorest countries (Fig.1.1).  TB has the highest incidence rates in countries that 
also have widespread HIV infections and continues to remain the leading cause 
of death among people with HIV/AIDS. [3]
 Two of the major recent events that hindered containment and treating of 
TB is the increased spreading of multi-drug resistant (MDR)-TB, M.tb resistant to 
first-line anti-TB drugs rifampicin and isoniazid, and the emergence of extensively 
drug resistant (XDR)-TB, M.tb resistant to first-line anti-TB drugs as well as to 
drugs in the quinolone family and additionally to at least one of the second-line 
anti TB drugs kanamycin, capreomycin and amikacin [4].  In 2009, there were 5.8 
million new cases of TB of which 12% were MDR-TB.  In July 2010 there were 58 
countries with at least one case of XDR-TB (WHO, Report on Global  
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Figure 1.1: Estimated TB incidence rates by country, 2009.  From the 2010 World Health 
Organization report on Global Tuberculosis Control.
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Tuberculosis Control 2010).  Due to its high cost and global incidence, TB should 
be a concern for everyone to consider.  Advancement is necessary in the basic 
sciences to help establish not only better drugs and treatment strategies, but 
better diagnostics as well.
TB Infection and the Granulomatous Response
 TB is spread from person to person via inhalation of aerosolized 
mycobacteria.  In humans TB is most commonly caused by Mycobacterium 
tuberculosis (M.tb), but can also be caused by M. bovis.  After M.tb is inhaled, it 
is phagocytosed by an alveolar macrophage.  The infected alveolar macrophage 
then expresses chemokines and cytokines resulting in the influx of mononuclear 
cells to the site of infection.  The M.tb-infected macrophage becomes the center 
of the granuloma which becomes surrounded by infected and uninfected 
macrophages in addition to foamy macrophages and other monocytic cells [5, 6].  
The granuloma can be solid (non-necrotic), caseous (necrotic) or end-stage 
cavitary (consolidation) [7-9].  Infected macrophages in the granuloma often 
undergo necrosis upon activation of the T-cell response [10].  Within the 
granuloma, M.tb is subjected to nutrient starvation and hypoxia which limits its 
growth significantly [11].  M.tb containment and restriction of growth is maintained 
until the host immune system is weakened to the point at which it can no longer 
maintain the infection resulting in the dissolution of the granuloma into caseous 
necrosis into the lung, resulting in pulmonary TB [6, 12].
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M. tuberculosis Pathogenesis
 M.tb is an intracellular pathogen that can survive and replicate inside 
macrophage phagosomes.  Upon infection of a host, M.tb is phagocytosed 
primarily by alveolar macrophages and is able to grow logarithmically for 
approximately two weeks until the adaptive immune response is activated and 
Interferon (IFN)ϒ contributes to restricting mycobacterial growth [13].  M.tb 
continues to survive as a successful pathogen avoiding complete clearance from 
the host by interfering with the cell death of the infected macrophage, altering the 
cytokine and cytokine receptor expression profile and protecting its endosome 
from exposure to various innate antimicrobial responses and acidification.  M.tb 
is able to persist comfortably for months, years or decades within the host.
 
M.tuberculosis Evasion of Immunity
 M.tb is uniquely able to evade host cellular killing mechanisms by 
interfering with the fusion of the mycobacteria-containing compartment with 
lysosomes such that it resembles an early endosome/phagosome.  One way that 
it does this is by inhibiting an increase of Ca2+ in the cytosol.  By doing so, 
calmodulin and CaMKII-facilitated recruitment of lysosomal hydrolases such as 
Cathepsin D is abrogated [14, 15], and the M.tb-phagosome is incompletely 
acidified [16-18], maintaining a pH of 6.4, and retaining early endosomal marker 
Rab5 GTPase [19-22].  
 Alternatively, M.tb interferes with the endocytic pathway and prevents the 
acidification of its compartment by blocking the insertion of vacuolar ATPase into 
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the phagosomal membrane [23].  M.tb can also interfere with the localization of 
inducible nitric oxide synthase (iNOS) to its phagosome by limiting the amount of 
time that it’s scaffolding protein EBP50, a Na/H+ exchange regulatory factor, is 
associated with the compartment in the cell thus preventing the release of 
reactive nitrogen intermediates (RNI) into the phagosome [24].  By blocking the 
progression of its phagosome to harsher climates in early infection, M.tb creates 
an environment amenable to replication and survival within the host.  
 Recent studies using Mycobacterium bovis BCG have demonstrated a 
zinc metalloprotease 1-mediated arrest of phagosome maturation.  Using Zmp1 
mutants, the group demonstrated an increase in presentation of MHC class II 
restricted antigens.  This suggests that M.tb’s ability to block phagosomal 
maturation not only aids in the evasion of lysosomal delivery, but also decreases 
M.tb’s immunogenicity [25].  Zmp1 has also been shown to inhibit caspase-1 
dependent activation and secretion of IL-1β [26].  The two are possibly linked 
because IL-1β is known to be sequestered in autophagosomes [27], a 
compartment known to become acidified, similarly to lysosomes, in macrophages 
with a high burden of M.tb [28].
 Immune evasion of M.tb is also achieved through components of the cell 
wall.  One glycolipid in particular, mannose capped lipidarabinomannan 
(ManLAM), inhibits the function of CD4+ T-cells by interfering with early events in 
T-cell receptor (TCR) signaling.  M.tb does this by inserting ManLAM into lipid 
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rafts in the membranes of T cells thus interfering with the T-cell’s ability to signal 
properly [29].  
 A unique capability of M.tb is that it virulent strains are able to influence 
the mode of cell death of it’s infected macrophage.  This contributes to it’s 
immune evasion repertoire because a cell destined for necrosis is unable to 
restrict mycobacterial growth.  However, infected macrophages that die via 
apoptosis are antimicrobial in nature.  One major mechanism that M.tb uses to 
influence the mode of cell death in macrophages is based on the balance of 
eicosanoid production upon infection.  In the case of Mycobacteria, virulent 
strains are known to stimulate LXA4  which is permissive for mycobacterial 
growth compared to avirulent strains conversely induce PGE2 [30-32].  Infection 
with virulent M.tb causes microdisruption of membranes, specifically the 
disruption of mitochondrial membranes leading to necrosis of the infected cell 
which is beneficial to the survival of M.tb within the host [33, 34].  Membrane 
repair in infected macrophages is dependent on the production of the eicosanoid 
prostaglandin E2 (PGE2), however infection with virulent M.tb stimulates the 
production of the eicosanoid Lipoxin A4 (LXA4) which blocks PGE2 and thus it’s 
membrane repair effects leading to necrosis of the infected macrophage and 
avoiding death by apoptotic cell death mechanisms of the host [35].
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Innate Immune Response to M. tuberculosis 
 Immune recognition of M.tb was recently well reviewed by Kleinnijenhuis 
et. al. describing toll-like receptors (TLRs) 2, 4 and 9 with their adaptor molecule 
MyD88 as the predominant method of initiating an immune response to M.tb 
infection [36].  In addition to TLR’s, other pattern recognition receptors (PRRs) 
such scavenger receptors, NOD2, Dectin-1, Mannose receptor and DC-SIGN are 
involved in sensing M.tb.  In general, upon M.tb binding to TLR receptors on a 
macrophage, the signaling cascade involving IL-1 receptor associated kinase 
(IRAK), TNF receptor associated factor (TRAF) 6, TGFβ-activated protein kinase 
1 (TAK1) and mitogen-activated protein (MAP) kinase leads to the activation and 
nuclear translocation of nuclear transcription factor (NF)-κB.  This leads to the 
production  of critical cytokines TNF, IL-1β and IL-12, and nitric oxide is produced 
[36].  Though several receptors are involved in the detection of M.tb by the 
immune system, the primary pathogen associated molecular pattern (PAMP) of 
M.tb that is sensed is the predominant cell wall glycolipid trehalose 6,6'-
dimycolate (TDM/cord factor).  Innate sensing of this molecule is mediated by 
class A scavenger receptor MARCO and TLR2 in a MyD88-dependent fashion 
resulting in a pro-inflammatory cytokine response [37].  Though TLR 2 and 4 
have been shown to be essential for controlling chronic TB disease in mice [38, 
39], they have a minimal impact and/or are dispensable for the acute response to 
M.tb infection [38, 40-44]. 
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 In contrast, IL-1 receptor signaling via MyD88 is required for acute control 
of M.tb infection [45, 46].  Mice deficient in MyD88 are extremely susceptible to 
TB infection despite that they are able to mount an antibody response [47, 48] 
due to defective IL-1R signaling [46].  Defective IL-1R signaling in mice not only 
results in diminished production of nitric oxide (NO) [49], but also lower 
production of IFNϒ, defective granuloma formation and lower survival [50]. 
Cytokines in the Immune response to M. tuberculosis
 Janeway defines cytokines as “proteins released by cells that affect the 
behavior of other cells that bear receptors for them” [51].  There are many 
cytokines involved in the immune response to M.tb and are reviewed very briefly 
in Table 1.1 [52].  Cytokines can be pro- or anti-inflammatory and both classes 
are required to combat infections successfully.  Cytokines are produced by a 
wide array of cells and include cells involved in innate immunity, adaptive 
immunity and in barrier protection of the host, such as endothelial and epithelial 
cells.  
 One cytokine of particular is of critical importance in the innate immune 
defense against M.tb infection and deserves special attention here: IL-1 [46, 53, 
54].  IL-1 family cytokines can be produced by macrophages (Mϕ), dendritic cells 
(DC), epithelial and endothelial cells.  IL-1 family cytokines are pro-inflammatory 
and consist of two types, IL-1α and IL-1β.  Both mature cytokines are initially 
found as pro-cytokines that require further processing for bioactivity, though 
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ProIL-1α is biologically active.  All of the effects of IL-1α are unknown however it 
is known that ProIL-1α can bind to DNA and is localized in the nucleus [55, 56].  
IL-1β is inactive until processed by caspase-1 and until that point, is maintained 
in the cytoplasm of the cell and is then exported [57, 58].  Signaling for both 
forms of IL-1 occur through binding to one of nine variations of the IL-1R.  Not all 
of the receptors are very well characterized though it is known that signaling 
through these receptors results in the release of IL-1β [58].  
 Important discoveries focusing on the role of IL-1 in M.tb infection have 
been recently made.  In a study using human peripheral blood mononuclear cells 
(PBMC’s), it has been shown that caspase 1-dependent IL-1β production is 
stimulated by M.tb by both the TLR2/TLR6 and NOD2 receptors.  The same 
study demonstrated that the the subsequent secretion of IL-1β from infected 
human PBMC’s was dependent on P2X7 receptor activation by endogenous 
ATP in supernatants [59].  Mayer-Barber et. al. have shown that IL-1R-/- mice are 
extremely susceptible to M.tb infection and that both IL-1α and IL-1β are 
important for host defense against M.tb and that these are regulated by 
interferons [53, 54].  There is evidence with some bacteria that components of 
the bacteria themselves can bind to ICAM molecules resulting in the activation of 
the NLRP3 inflammasome components resulting in the production of IL-1 though 
evidence of this with M.tb is not yet defined [60].
 Though IL-1β plays a role in protecting the host from devastation by TB, 
as a successful pathogen, virulent M.tb is able to inhibit IL-1β production.  One 
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way M.tb modulates IL-1β is by stimulating type 1 interferon (IFN) resulting in 
decreased production of IL-1β at the mRNA level (as opposed to the level of 
caspase activation of pro-IL1 to its mature form or by IL-1β autocrine 
amplification) in addition to decreased expression of IL-1R [61].  Additionally, 
M.tb encodes a Zn2+ metalloprotease, Zmp1, that reduces IL-1β production by 
about 10-fold by inhibiting caspase 1 activity [26].  These studies suggest a 
prominent role for IL-1β in the host defense against TB.
The role of Eicosanoids in M.tuberculosis Infection
 Arachidonic acid (AA) released from cell membranes by the enzyme 
phosphlipase A2 is the originating source of eicosanoids.  Following release from 
the membrane, AA is converted to specific molecules by cyclooxgenase (COX) 
and lipoxygenase enzymes.  The resulting molecules are classified into four 
families: prostaglandins, prostacyclins, thromboxanes and leukotrines [62].  
Eicosanoids range in function and are known to be both pro- and anti-
inflammatory in nature.  These molecules exert their effects by acting on G-
protein coupled receptors and are known to be involved in asthma, cancer, 
rheumatoid arthritis, tissue remodeling and other autoimmune disorders [63]. 
 Additionally, infection with various species of bacteria can trigger very 
different eicosanoid production profiles.  As described above, virulent strains of 
mycobacteria are known to stimulate LXA4  which is permissive for mycobacterial 
growth compared to avirulent strains conversely induce PGE2 [30-32] and M.tb’s 
10
Cytokine Producing 
Cells
Effect
IL-12 Mϕ, DCʼs -induced after phagocytosis of M.tb
-stimulates Th1 response
IFNγ CD4+, CD8+ T-
cells, NKʼs
-activates macrophages
-sufficient to control M.tb infection
TNFα Mϕ, DCʼs, 
T lymphocytes
-synergizes with IFNγ to induce NOS2 
expression 
IL-1 Mϕ, 
monocytes, 
DCʼs, 
epithelial cells
-important for the acute phase response
-facilitates T lymphocyte expression of IL2R 
and IL-2 release
IL-2 CD4+  T-cells -lymphocyte expansion
IL-10 Mϕ, T-cells -Mϕ deactivation and downregulation of IL-12 
and IFNγ
-reduces CD4+ T-cell response
TGFβ monocytes -deactivates Mϕ production of ROI & RNI
-inhibits T-cell proliferation
IL-8 Mϕ, 
monocytes
-recruits neutrophils, T-lymphocytes and 
basophils
-neutrophil activating factor
Table 1.1: Cytokines in the immune response to M.tuberculosis.  A brief description of the 
general cytokines involved in the immune response to M.tb as reviewed by Raja [52, 54].
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ability to promote the production of LXA4 as opposed to PGE2 allows for M.tb to 
evade clearance from the host via apoptosis-dependent antimicrobial pathways 
[35]. Generally, Leukotrines and hepoxilins are involved in mounting an 
inflammatory response and prostaglandins and lipoxins are more involved in 
reducing an immune response.  Cells of the innate immune system, including 
macrophages, neutrophils and dendritic cells (DC’s) are known to produce 
eicosanoids in order to influence the immune response to a pathogen [63].  For 
example, macrophages will decrease production of pro-inflammatory TNFα and 
increase production of anti-inflammatory IL-10 in response to prostaglandin E2 
(PGE2) [64, 65].  
 
Adaptive Immune Response to M. tuberculosis 
 The current understanding of the adaptive immune response to M.tb is 
predominantly based on cell-mediated immunity by T-lymphocytes.  Literature 
supporting protective effects of humoral immunity of TB mediated by B-
lymphocytes is extremely unclear and contradictory in nature [66].  The human T-
cell response to M.tb involves CD4+,CD8+ and γδ T-cells though it was originally 
thought that CD4+ T-cells would have a greater role in the control of M.tb 
infection because MHC class II molecules have access to phagosomes and other 
compartments within cells which increases M.tb specific antigen presentation 
[67].  The primary role of M.tb specific CD4+ cells is in producing cytokines, 
specifically tumor necrosis factor (TNF), IFNγ and IL-2.
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 The precise role of cytotoxic T-cells (CD8+) is unclear.  Winau et. al. 
hypothesize that CD8+ T-cells are activated as a result of infected macrophages 
undergoing apoptosis thus serving as a cross-priming mechanism [68].
What is clear however is that lungs and granulomas in non-human primates 
infected with M.tb contain equal proportions of CD8+ and CD4+ T-cells [69].  It is 
well understood that patients with latent M.tb infection have increased levels of 
CD8+ T-cells [70, 71].  Mouse model studies suggest that CD8+ cytotoxic T-cells 
could be protective in M.tb infection in two ways.  The first is by a perforin & 
granulysin mechanism resulting in the lysis of a M.tb-infected macrophage 
followed by direct killing of M.tb bacilli, or secondly via Fas-FasL mediated lysis 
of an infected macrophage that results in the release of M.tb allowing nearby 
activated macrophages to take up and kill the bacilli [72].  
 Though both adaptive and innate immune mechanism contribute to 
controlling M.tb infection, it is unclear where one system ends and another 
begins.  One cell type in particular, γδ T-cells, play a significant role in bridging 
the gap between the adaptive and innate immune responses to M.tb infection 
[73-77].  Some insightful studies have demonstrated that upon infection with 
M.tb, macaque’s show a significant increase of γδ T-cells in tissues and lymph 
nodes but not in the blood [78].  These studies also demonstrate that γδ T-cells 
undergo clonal expansion and display functional memory in response to M.tb 
phosphoantigens, a classically adaptive immune function in addition to producing 
the cytotoxic granule molecule granzyme B in response to a high M.tb burden 
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within lung granulomas [78].  Furthermore, there is a significant number of 
studies supporting the role of γδ T-cells in the immune response to M.tb.  γδ T-
cells can recognize M.tb antigens via monocytes in a non-MHC restricted manner 
can be directly activated by mycobacterial phosphoantigens [79-81].   γδ T-cells 
can also be activated by TLR signals, especially TLR3 and TLR9 ligands [82-84], 
and additionally by IL-15, a T-cell specific growth cytokine, produced by 
monocytes in response to M.tb infection [85].  Both the memory functions of γδ T-
cells and the ability of the subset of cells to respond directly to M.tb and other 
innate immunity signaling molecules suggests a unique role of these cells in the 
immune response to M.tb.
Autophagy
 Autophagy is cellular homeostatic process most widely recognized for 
enabling the cell to clean up the cytoplasmic space and rid itself from potentially 
harmful cellular constituents such as protein aggregates and damaged 
mitochondria [86].  It was first identified, however, as a mechanism used to 
degrade cellular contents under nutrient depletion conditions as a means to 
maintain cellular anabolic needs [87].  In addition to being a constitutive cellular 
“housecleaning” mechanism, autophagy is activated by cell stress responses, for 
example in response to nutrient deprivation, activated in response to intracellular 
infections and also as a mode of type II cell death [88].
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 The activation mechanism differs between the different stimuli of 
autophagy, however, they all result in the formation of a double membrane (often 
referred to as “isolation membrane”) and converge on LC3 recruitment to the 
phagophore.  This membrane comes from a variety of sources, namely the 
endoplasmic reticulum (ER), the plasma membrane and mitochondria [89-95] 
and the formation of the phagophore from cellular membranes is mediated by 
autophagy related protein (ATG) 16L [93].  ATG16L is critical for coupling 
membrane acquisition and autophagosome biogenesis and additionally appears 
to influence whether or not the phagophore will mature into a LC3-positive 
autophagosome [94] required for the formation of mature autophagosomes.
Autophagy and the immune response to M. tuberculosis infection
 Autophagy can be induced not only by environmental stimuli, but also by a 
number of molecules associated with the immune response to pathogens, both 
from the host and the pathogen.  It is a cellular mechanism that responds 
effectively to numerous innate immune signals yet also regulates cytokine 
secretion.  It is a process that bridges innate and adaptive immunity by 
increasing antigen presentation to T cells [96].  Because of its antigen 
presentation abilities, it is not surprising that autophagy can be regulated by Th1 
cytokines, which promote autophagy and antimicrobial mechanisms, and Th2 
cytokines, which are known to inhibit IFNϒ induced autophagy and yet again, 
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presents another mode of interference with antimicrobial mechanisms for 
pathogens to manipulate within its host [97].  
 Treating M.tb-infected macrophages with ATP, IFNϒ and rapamycin 
induces autophagic killing of mycobacteria in vitro at least in part by stimulating 
maturation of its phagosome [98-100].  This effect can be reversed by siRNA 
treatment against Beclin 1, Irgm1 or Atg7 [99, 101, 102].  It has been suggested 
that IFNϒ induced autophagy may depend on TNFα autocrine signaling based on 
findings that TNF blockers inhibit IFNϒ induced autophagy though the 
mechanism is not well understood [103, 104].  Evidence of M.tb-induced 
autophagy without addition of exogenous IFNϒ and direct in vivo relevance of 
autophagy in the immune response to TB has yet to be determined. 
M. tuberculosis-induced Cell Death
 In the last 15 years, it has become widely recognized that the fate of the 
infected cell also determines the fate of M.tb [105].  A unique feature of virulent 
strains of mycobacteria, such as M.tb H37Rv and M.bovis, is that at a low 
multiplicity of infection (MOI) it evades TNFα-mediated apoptosis in primary 
murine macrophages, a mode of cell death that restricts bacillary growth that 
attenuated and avirulent strains of mycobacteria such as M.bovis BCG and M.tb 
H37Ra are unable to inhibit. [1, 106]  The original idea that M.tb might 
manipulate the host cell death mechanism for an exit strategy to not only infect 
more cells within a single host but to increase host-to-host spreading was 
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suggested by Lee et. al. [2].  This idea stemmed from evidence that cytolytic 
viruses are able to modulate antiapoptotic signals to support their own replication 
and ultimately allow for their spread [107].  
 To mimic the point during infection that M.tb would be ready to escape 
from its initially infected macrophage, the high MOI model was established.  This 
is a model that remained unvalidated until recently due to the long-term latency 
associated with TB infection in patients.  Most studies have focused on the time 
during infection when M.tb is not able to replicate and is minimized to 
approximately 1-2 bacterium per cell.  However, one recent in vivo study showed 
that in M.tb lesions in control mouse lungs at 15 days post-infection by aerosol, 
had numerous occurrences of heavily infected cells (Fig. 1.2) [108].
 The findings of the high MOI study established a novel mode of cell death 
initiated by the live, virulent strain M.tb Erdman that initially mimicked apoptosis 
but rapidly transitioned to a necrotic mode of cell death, a process here on out 
referred to “apoptonecrosis”.  Apoptonecrosis is unique from TNF-dependent 
apoptosis and favors the survival of the mycobacteria and independent from the 
typical caspases and Fas signaling usually present in apoptotic cell death [2].  
This was the first evidence of a cell-death induced escape mechanism for M.tb 
and suggested that apoptosis of M.tb -infected cells is good for the host and 
necrotic-predominant forms of cell death favors M.tb survival.
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FIGURE 1.2: Anti-PPD immunohistochemistry of lung sections from control mice with TB. 
Mice were infected with ~100 CFU Mtb Erdman by aerosol and then lungs were isolated 15 d 
later for immunohistochemistry with H&E counter stain. M.tb-infected macrophages are 
distinguished by brown staining (X 400 magnification).  [108]
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 Though the mode of high MOI cell death induced by M.tb is not directly 
microbicidal, depending on the circumstances surrounding the infected 
macrophage, the opportunity for antimycobactericidal effects remain.  The idea 
that programmed cell death of Mycobacterium-infected macrophages would 
serve as a way to sequester the infection and enhance the immune response 
was originally presented by Fratazzi et. al. [105].  Their data showed that the 
interaction between Mycobacterium avium (M.avium)-infected, apoptotic human 
peripheral blood mononuclear cells (PBMCs) and non-apoptotic PBMCs reduced 
the viability of M.avium yet when the infected cells were made necrotic by 
sonication, there was no reduction in M.avium viability.  This experiment was 
repeated by our lab using M.tb Erdman in the context of the high MOI model 
using early time points, 3 hours post infection, of heavily infected macrophages 
to model the apoptotic cell death state and later time points, 24 hours post-
infection, to model necrosis of infected cells [2].  These experiments confirmed 
the early observations by Fratazzi et. al. but additionally identified approximate 
kinetics of when macrophages with a heavy burden of M.tb would be either 
apoptotic or necrotic [105].  Additionally, experiments by Lee et. al. identified a 
window in time where heavily infected, dying macrophages would be able to 
exert antimicrobial effects on intracellular M.tb with the help of naïve 
macrophages added to the culture, which we believe models the recruitment of 
naïve macrophages to the site of infection in the lung [2].  Together, these data 
suggest that manipulation of the mode of cell death of the infected macrophage 
19
is critical to the survival mechanism of M.tb.  The goal of the work in presented in 
this dissertation was to identify the mechanism and factors involved in the cross-
talk between macrophages with a high burden of M.tb and naïve ones.
20
PREFACE to Chapter II
A modified version of this chapter has been published:
Hartman, ML, Hardy Kornfeld.  Interactions between naive and infected 
macrophages reduce Mycobacterium tuberculosis viability.  PLoS One.  2011; 6
(11): e27972.
This manuscript represents the main thesis project of Michelle Hartman, who 
contributed to its conception, experimental design, generated all data with 
subsequent analysis, and assisted in writing the associated manuscript.
21
Acknowledgements
I’d like to acknowledge Dr. Shruti Sharma of Dr. Kate Fitzgerald’s lab at 
University of Massachusetts Medical School for the countless discussions we 
had regarding the possibility of the role of IL-1b and activation of the 
inflammasome in the co-culture conditions.  Without her suggestions, IL-1 would 
likely not have been pursued and we would have missed out on it’s involvement 
in our system.  I’d also like to thank Dr. James Harris from Trinity College Dublin 
for his overall insightfulness and contribution of ideas for the direction of the 
project described in this chapter.
22
CHAPTER II: Interactions between Naive and infected 
Macrophages Reduce Mycobacterium tuberculosis Viability
ABSTRACT
 A high intracellular bacillary load of Mycobacterium tuberculosis in 
macrophages induces an atypical lysosomal cell death with early features of 
apoptosis that progress to necrosis within hours. Unlike classical apoptosis, this 
ultimately necrotic macrophage cell death does not directly impair M. tuberculosis 
viability. We previously reported that culturing heavily infected macrophages with 
naïve macrophages produced an antimicrobial effect, but only if naïve 
macrophages were added during the pre-necrotic phase of M. tuberculosis-
induced cell death. In the present study, we investigated the mechanism of 
antimicrobial activity in co-culture settings, anticipating that efferocytosis of bacilli 
in apoptotic bodies would be required. Confocal microscopy revealed frustrated 
phagocytosis of M. tuberculosis-infected macrophages with no evidence that 
significant numbers of bacilli were transferred to the naïve macrophages. The 
antimicrobial effect of naïve macrophages was retained when they were 
separated from infected macrophages in Transwell® plates, and conditioned 
supernatants from co-cultures transferred antimicrobial activity to cultures of 
infected macrophages.  Antimicrobial activity in macrophage co-cultures was 
abrogated when the naïve population was deficient in IL-1R or when the infected 
population was deficient in inducible nitric oxide synthase. The participation of 
nitric oxide suggested a conventional antimicrobial mechanism requiring delivery 
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of bacilli to a late endosomal compartment. Using macrophages expressing GFP-
LC3 we observed the induction of autophagy specifically by a high intracellular 
load of M. tuberculosis. Bacilli were identified in LC3-positive compartments and 
LC3-positive compartments were confirmed to be acidified. Thus, the 
antimicrobial effect of naïve macrophages acting on M. tuberculosis in heavily-
infected macrophages is contact-independent. Interleukin-1 provides an afferent 
signal that induces an as yet unidentified small molecule which promotes nitric 
oxide-dependent antimicrobial activity against bacilli in autolysosomes of heavily-
infected macrophages. This cooperative, innate antimicrobial interaction may limit 
the maximal growth rate of M. tuberculosis prior to the expression of adaptive 
immunity in pulmonary tuberculosis.
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Introduction
A role for apoptosis in innate defense against Mycobacterium tuberculosis 
(M.tb) was suggested by evidence demonstrating that attenuated M.tb H37Ra 
and M. bovis BCG induced tumor necrosis factor (TNF) α stimulated apoptosis in 
infected macrophages, which was associated with a reduction in bacillary viability 
[1, 109]. In addition to the direct antimicrobial processes occurring in apoptotic 
macrophages, a previous study by Fratazzi et al. [105] demonstrated that the 
addition of naïve macrophages to macrophages infected with an apoptosis-
inducing strain of M. avium strongly inhibited bacillary growth. This co-culture 
effect was observed when the infected cells were apoptotic, but not if they were 
made necrotic by sonication.
 The host-protective effects of apoptosis in tuberculosis (TB) is now an 
accepted paradigm, but its biological relevance is uncertain since virulent M.tb 
inhibits the apoptotic death of infected macrophages [1] and uses these cells as 
a replication niche.  Lee et al. [2] reported that virulent M.tb induces an atypical, 
ultimately necrotic mode of macrophage cell death at a threshold intracellular 
burden of 25 bacilli per macrophage.  In the first several hours after high 
multiplicity of infection (MOI) challenge, infected macrophages have apoptotic 
features of nuclear condensation and phosphatidylserine (PS) externalization 
without apoptotic vesicle formation.  Adding naïve macrophages during this pre-
necrotic interval was shown to inhibit M.tb replication, whereas adding naïve 
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macrophages at 24 h post-infection when the infected population was necrotic 
had no antimicrobial effect.
 In the present study we investigated the mechanism responsible for 
inhibiting M.tb replication in co-cultures of naïve and infected macrophages, 
initially testing the hypothesis that this depended on phagocytosis of apoptotic 
bodies (efferocytosis) by the naïve population.  Results did not support that 
hypothesis: confocal microscopy demonstrated incomplete engulfment of 
infected macrophages (“frustrated efferocytosis”) and the antimicrobial effect 
contributed by naïve macrophages was found to be contact-independent. We 
show that naïve macrophages are stimulated in an interleukin-1 receptor (IL-1R)-
dependent manner to produce a soluble factor that acts back on heavily infected 
macrophages to restrict M.tb growth in a nitric oxide-dependent manner. This 
implies the delivery of bacilli to a late endosomal compartment, and in that regard 
we showed that a high intracellular M.tb load is sufficient to induce autophagy in 
macrophages. Our data reveal cross talk between infected and uninfected 
macrophages that inhibit M.tb replication, most likely by promoting antimicrobial 
processes in autolysosomes prior to the completion of M.tb-induced necrosis. 
These interactions may serve to limit the maximal proliferative potential of M.tb 
during the early phase of pulmonary TB before the induction of adaptive 
immunity.
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Results
Cell contact is not required for co-culture antimycobacterial activity 
 Previous studies of macrophages infected with M. avium or M.tb 
demonstrated that co-culture with naïve macrophages restricted mycobacterial 
growth, but only when the originally infected cells exhibited features of apoptosis 
[2, 105].  It was speculated in those reports that antimycobacterial activity might 
depend on uptake of bacilli by uninfected macrophages via efferocytosis of 
apoptotic host cells, but this was not formally tested.  To investigate that question 
we first assessed whether efferocytosis occurs in co-cultures where naïve 
immortalized cell line macrophages, with Cholera toxin subunit B (CTX)-488 
stained membranes, were added to M.tb infected (MOI 50) macrophages, with 
membranes stained with CTX-647, which had been infected 3 h earlier with.  
Under these conditions the infected population is committed to death and 
externalizes phosphatidylserine (PS) but would not have progressed to necrosis, 
which is not widespread until 24 h post-infection.  Samples were fixed at 4, 6, 
and 8 h after co-culture and examined by confocal microscopy.  Interactions 
between infected and uninfected macrophages consistent with early or attempted 
engulfment were evident at all time points.  Figure 2.1A shows pedestal formation 
and partial engulfment of whole infected cells at the synapse between these cell 
populations (white arrows).  Complete internalization of infected macrophages 
was not observed even after 24 hours of co-culture.  These interactions were 
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Figure 2.1: Attempted engulfment of M.tb-infected macrophages by naïve macrophages is 
incomplete and unidirectional. (A)  Infected macrophages (red) were co-cultured with 
uninfected macrophages (green) for 3 h. Samples were fixed and observed by laser-scanning 
confocal microscopy. White arrow identifies early contact points where naïve macrophages form 
pedestals or partially engulf infected macrophages. (B) Directionality of frustrated efferocytosis 
was quantified by counting the number of “positive” interactions, ones in which naïve 
macrophages form pedestals or partially engulf infected macrophages, compared to “negative” 
interactions where cell-cell contact occurred without pedestals or engulfment (all interactions not 
described as “positive”). Results are expressed as the % positive interactions vs. % negative 
interactions at each time point ± SD.  ***, p < 0.0001 for all time points
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almost exclusively unidirectional, with uninfected cells forming pedestals on 
infected macrophages only partially engulfing them (Fig. 2.1B).  This indicated 
that these interactions were not random but mediated through an “eat me” signal 
such as PS on the surface of the infected cells.  The apparent failure to 
completely internalize all or parts of infected macrophages suggests that these 
interactions (in the absence of apoptotic vesicle formation) might reflect 
frustrated efferocytosis by analogy to frustrated phagocytosis [110].
 To test whether physical contact between naïve and infected macrophages 
was required to limit M.tb replication, infected and uninfected macrophages were 
separated with a 0.4µm pore size polycarbonate Transwell® filters for the 
duration of the co-culture.  Colony forming units (CFU) were measured at 3, 48 
and 72 h post addition of naïve macrophages.  As shown in Figure 2.2a, 
separation of the macrophage populations by transwell did not change the 
outcome of the co-culture antimycobacterial effect.  This demonstrated that 
contact between naïve and M.tb-infected macrophages is not necessary for this 
phenomenon to occur, implying the production of a soluble factor by naïve 
macrophages acting to limit M.tb replication in during the early, pre-necrotic 
phase of cell death in the infected population.
 To test whether a soluble factor expressed in co-cultures was sufficient for 
the observed antimycobacterial effect, we collected supernatants from co-
cultures of naïve and M.tb-infected macrophages 3 h after co-culture began.  
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Figure 2.2: Interactions between infected and naïve macrophages results in the production 
of a soluble factor that reduces M.tb viability. (A) Immortalized cell line macrophages infected 
with M.tb Erdman (MOI 50) were cultured alone or in the presence of uninfected macrophages 
separated by Transwell® polycarbonate membranes. Results are expressed as mean CFU per 
mL ± SD at the indicated time points. *, p = 0.018 comparing co-cultures of M.tb-infected plus 
uninfected macrophages to infected macrophages alone at 72 h. (B) Filter-sterilized supernatant 
from macrophage co-cultures was added to wells contained isolated, infected macrophages 
alone.  Transfer of co-culture supernatant reduced M.tb viability demonstrating that the factor 
responsible for the effect is soluble. *, p < 0.0001; **, p = 0.002.
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Supernatants were filter-sterilized (0.22 µm) to remove bacilli or debris before 
being added to new cultures of infected macrophages and then CFU was 
measured 3, 24 and 72 h later.  Antimicrobial activity was transferrable (Fig. 2.2b) 
and operated only in the context of infected macrophages in the early, apoptotic, 
phase of M.tb-induced death. These results indicated that the co-culture 
antimycobacterial effect was mediated by a soluble factor produced by naïve 
macrophages that acted on infected, pre-necrotic macrophages to limit M.tb 
growth.  This activity was produced by naïve macrophages within 3 h of co-
culture and did not require physical contact with infected macrophages, implying 
also the existence of a soluble afferent factor produced by the dying cells.  
Interleukin-1 is an afferent signal in co-cultures
 The involvement of soluble signals in the crosstalk between infected and 
uninfected macrophages in this high burden condition suggested a possible role 
for cytokines. Screening co-culture supernatants by ELISA revealed several 
cytokines whose levels increased following the addition of naive macrophages.  
(Fig. 2.3); among these were IL-1β.  To further investigate the role of IL-1 in the 
context of high MOI co-culture conditions, we tested whether IL-1R signaling was  
required as an afferent, death-associated signal to induce production of a 
secreted efferent factor from naïve macrophages limiting M.tb replication in 
infected macrophages.  Co-cultures were established, and IL-1R-/- immortalized 
cell line macrophages replaced wild type cell line macrophages either as the 
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Figure 2.3: Cytokine profile of M.tb-infected macrophages in the presence or absence of 
naïve macrophages. Macrophages were infected with M.tb Erdman (MOI 50) for 3 h then 
cultures were washed and the infected cells were resuspended in medium alone or medium plus 
an equal number of naïve macrophages. After an additional 3 h in culture, supernatants were 
collected, and frozen at -80°C until multiplex cytokine analysis. Concentrations of IL-1β and IL-18 
are shown for co-cultures of infected and uninfected macrophages (add back) or culture of M.tb-
infected macrophages without naïve macrophages (no add back).
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Figure 2.4: (A) Antimycobacterial activity in macrophage co-cultures requires IL-1R 
expression on the naïve cell population.  Co-cultures were established with M.tb-infected 
IL-1R-/- cell line macrophages and uninfected wild type cell line macrophages (IL-1R-/- AB WT) or 
vice versa (WT AB IL-1R-/-) and co-incubated for up to 48 hours. CFU was measured at 0 and 48 
h post-addition of naïve macrophages. Results are expressed as the difference in mean CFU/ml 
± SD comparing baseline CFU to T(48).  **, p = 0.009.  (B) Neutralization of IL-1 with antibodies 
abrogates antimycobactericidal activity in co-culture supernatants.  Co-cultures were 
established with M.tb-infected and uninfected wild type cell line macrophages.  Neutralizing or 
control antibodies were added to a final concentration of 50µg/mL.  CFU was measured at 0 and 
48 h post-addition of naïve macrophages. Results are expressed as the difference in mean CFU/
ml ± SD comparing baseline CFU to T(48).  **, p < 0.0055; *, p = 0.048.
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infected or naïve population (Fig. 2.4).  These experiments demonstrated that the 
co-culture antimycobacterial activity required IL-1R expression in naïve but not 
infected macrophages.  This suggested that IL-1β served as an afferent signal to 
directly or indirectly induce the expression of a soluble efferent factor from naïve 
macrophages.
 To further test the involvement of IL-1α and IL-β in the co-culture 
antimycobacterial effect, we neutralized the cytokines both individually and in 
unison in a co-culture experiment (Fig. 2.4B).  Neutralizing antibodies, were 
added at the same time as the naïve macrophages and remained in co-culture 
until CFU/mL was measured.  Neutralization of both IL-1α & β was sufficient to 
abrogate the co-culture antimycobacterial effect.  Neutralizing both IL-1α & β in 
unison was slightly more permissive for M.tb growth compared to IL-1α or β 
separately suggesting the possibility that the two cytokines are working 
synergistically but separately.  This supports the idea that IL-1 is an important 
signaling molecule in the innate immune response to M.tb infection in 
macrophages.  The additive effect of IL-1α & β also suggests that the 
communication between the infected and uninfected macrophage populations is 
complicated and likely to involve multiple signals not yet identified.
 We then investigated whether activating macrophages with recombinant 
IL-1α, IL-1β or both was sufficient for the infected macrophages to confer the 
antimycobacterial activity (Fig. 2.5).  Macrophages were pre-treated with IL-1α, 
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IL-1β or both for one hour prior to infection and  2 hours during infection in the 
absence of naive macrophages.  Pre-treatment with IL-1 was not sufficient for 
enabling the antimycobacterial effect of infected macrophages, supporting the 
idea that IL-1 is serving as an afferent signal to the naive macrophages.
The efferent signal in co-cultures is elusive
 Having found that IL-1β participates as an afferent factor in the co-culture 
system, we sought to understand the mechanism of its expression and also to 
identify the factor present in co-culture supernatant that inhibited M.tb replication.  
It was previously suggested that signaling via ATP receptor, P2X7, (P2X7 R),  can 
activate the NLRP3 inflammasome leading to caspase-1 activation and IL-1β 
release [111-115] and is modeled to be involved in lung inflammation associated 
with chronic obstructive pulmonary disease (COPD) [116].  Moreover, stimulation 
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Figure 2.5: Pre-Treating Macrophages with IL-1 before infecting with high MOI M.tb does 
not reduce bacterial viability.  Naïve macrophages were pre-treated for one hour with 100 ng/
mL with IL-1α, IL-1β or both prior to infection.  Macrophages were infected with M.tb Erdman 
(MOI 50) for 2 h, with IL-1 remaining in the media, then infected macrophages were washed and 
kept in DMEM without IL-1 until CFU was measured.  CFU was measured at 2, 8 and 24 hours 
post-infection.  Results are expressed as the difference in mean CFU/ml ± SD comparing 
baseline CFU to T(24).  *, p < 0.0005
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of P2X7R in M.tb-infected macrophages was shown to induce antimycobacterial 
activity by directing bacilli to autophagosomes [117, 118].  We investigated the 
involvement of ATP-mediated signaling by establishing co-cultures where either 
the infected or the uninfected macrophages were derived from P2X7R-/- mice.  
Regardless of what population was deficient of P2X7R, there was no reduction of 
antimycobacterial activity (Fig 2.6a).  This result indicated that P2X7R signaling 
was not required for either afferent or efferent limbs of antimicrobial activity 
observed in the co-culture system.  
 When the nucleotide adenosine is released from stressed and dying cells 
it can often have immunomodulatory effects.  It was reported that IL-1β increases 
adenosine receptor expression in monocytes and increases responsiveness to
adenosine [119].  In co-cultures established with macrophages from adenosine 
A2a receptor-/- mice we found no reduction of antimycobacterial activity when 
these cells were used either as the naïve or infected population (Fig. 2.6b).  
Furthermore, treating infected macrophages with the stable adenosine agonist 
NECA at 0.1, 1 and 10 µM, did not limit M.tb replication in infected macrophages 
(Fig. 2.6c).  Direct antimicrobial activity of NECA was tested at 1 µM and did not 
affect bacterial replication (Fig. 2.6d).  These results effectively excluded a 
requirement for adenosine for antimicrobial activity.
 To define the physical nature of the efferent co-culture factor, supernatants 
were treated with DNAse, RNAse, proteinase K and at denaturing temperatures 
(Fig. 2.7).  None of these treatments reduced the antimycobacterial effect 
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Figure 2.6: Nucleotide signaling does not contribute to the antimycobacterial activity in 
macrophage co-cultures.  (A) Co-cultures were established using wild type immortalized 
BMDM’s infected with M.tb and naïve  P2X7 receptor-deficient macrophages (WT AB P2X7R-/-) or 
vice versa. CFU per mL was measured at the indicated times. The co-culture antimicrobial effect 
was observed in both conditions. (B) Co-cultures were established with M.tb -infected wild type 
immortalized BMDM’s and naïve adenosine A2a receptor-deficient macrophages (WT AB A2a-/-) 
and vice versa. CFU per mL was measured at time zero and 48 hours post-addition of treated 
supernatants. Adenosine A2a receptor expression on either cell population was dispensable for 
M.tb growth inhibition.  (C) High MOI co-culture experiment was carried out in the presence of 
P2X7 receptor antagonist, N-ethylcarboxamidoadenosine (NECA) at 0.1, 1 and 10µM starting at 
the time of addition of the naïve immortalized BMDM’s to the infected ones.  CFU was measured 
at 3 and 20 hours after the addition of NECA and naïve macrophages.  To verify that NECA did 
not have any direct antimicrobial effects, M.tb was incubated in media alone containing 1µM 
NECA  (D). CFU was measured at 3 and 20 hours after adding NECA to the bacterial culture.
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Figure 2.7: Soluble antimicrobial activity in macrophage co-cultures is not mediated by 
DNA, RNA or protein.  Supernatants were harvested from co-cultures of M.tb-infected and naïve 
cell line macrophages, filter-sterilized and then treated as described before being added to 
isolated cultures of macrophages infected with M.tb (MOI 50, 3 h). CFU per mL was measured at 
time zero and at the indicated times post-addition of treated supernatants. (A) Treating co-culture 
conditioned supernatant with DNase or RNase failed to eliminate antimicrobial activity. (B) Co-
culture conditioned supernatants were treated with proteinase K and then heated to 95oC for 5 
min, or passed through the indicated size-exclusion filters before being added to M.tb-infected 
macrophages. These treatments failed inhibit the ability conditioned supernatant to promote 
inhibition of M.tb replication in the heavily-infected macrophages.
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conferred by co-culture supernatants.  Passing co-culture supernatant through a 
series of molecular size exclusion filters to a minimum of 3 kDa also failed to 
deplete the activity.
 Phospohlipase A2 liberates arachidonic acid from membrane 
phospholipids which, through activities of cyclooxygenases (COX), 
lipoxygenases (LO) and cytochrome P450s, can be converted to a multitude of 
bioactive molecules, including eicosanoids, that affect numerous biological 
processes [120].  Stimulation of TLRs, especially TLR 4, can up-regulate COX-2 
and additionally modulate eicosanoid release [121].  Given the involvement of 
TLR 4 to M.tb recognition, we set out to determine whether inflammatory COX-
derived lipids were involved in mediating the co-culture antimycobacterial effect.  
To do this, naïve macrophages were treated with non-selective COX-1 inhibitor, 
indomethacin (Fig. 2.8a) and an irreversible COX-1 and COX-2 inhibitor aspirin 
(Fig. 2.8b).   Both failed to diminish the co-culture activity, indicating the efferent 
factor or its production did not depend on COX enzymes in the naïve cells. These 
experiments revealed that the efferent factor in this system is a heat-stable small 
molecule and not likely to be a protein, nucleic acid, prostaglandin or 
thromoboxane.  The identity of the factors involved remains to be determined.
Mechanism of antimycobacterial activity in co-cultures
 Having been unable to identify the soluble efferent factor in the co-culture 
experiments we turned our attention to the cellular requirements for the observed 
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Figure 2.8: Soluble antimicrobial activity in macrophage co-cultures is not dependent on 
COX-2 generated eicosanoids.  (A) Macrophages infected with MOI 50 M.tb were co-cultured 
with either naïve WT macrophages (WT AB WT) or macrophages that had been pre-treated with 
indomethacin for 3 hours prior to being added to the infected cells.  For groups with indomethacin 
pre-treated macrophages, co-culture was carried out both with indomethacin in the co-culture 
(Indo in Co-Culture) or without indomethacin (Indo washed out of co-culture).  (B) Co-cultures 
were established using wild type macrophages infected with M.tb and naïve aspirin pre-treated 
macrophages (WT AB Aspirin treated macs) or vice versa.  CFU was measured at 0 and 48 hours 
after addition of naïve macrophages were added to the infected ones.
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antimicrobial effect.  Our previous experiments indicated that the factor acted 
only on dying macrophages before the onset of necrosis, which suggested that 
the efferent factor induced or facilitated an intracellular antimicrobial process in
the infected macrophages.  Nitric oxide is a major factor limiting M.tb growth in 
macrophages; a function that has been demonstrated in vitro and in vivo 
[122-125].  To investigate any involvement of nitric oxide in the antimycobacterial 
effects observed in our experiments, we established co-cultures using inducible 
nitric oxide synthase (iNOS)-/- macrophages as the infected or the naïve 
population(Fig. 2.9).  When iNOS-/- macrophages were the infected cell 
population, co-culture with naïve macrophages failed to limit M.tb growth.  In 
contrast, naïve iNOS-/- macrophages were capable of stimulating 
antimycobacterial activity in wild-type macrophages infected with M.tb.  This 
result suggested that the efferent factor released from naïve macrophages 
facilitated a conventional antimycobacterial function in the infected cells that acts 
on bacilli in mature phagolysomes.  A cardinal feature of M.tb virulence is the 
capacity to arrest phagosome maturation and establish an intracellular 
compartment resembling an early endosome that is permissive for bacillary 
replication [19].  In this regard, Davis et al. [24] reported that iNOS is excluded 
from M.tb phagosomes.  Results from our experiment with iNOS-/- macrophages 
imply that in heavily infected macrophages, bacilli may be located in acidified 
lysosomal compartments.
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Figure 2.9: Antimycobacterial activity in macrophage co-cultures requires iNOS but not 
GP91phox expression in the infected cell population. (A) Co-cultures were established with 
M.tb-infected iNOS-/- macrophage cell lines and uninfected wild type macrophage cell lines 
(iNOS-/- AB WT) or vice versa (WT AB iNOS-/-) and also wild type macrophage cell lines co-
cultured with naive wild type macrophage cell lines (WT AB WT).  (B) Co-cultures were 
established with M.tb-infected wild type macrophages and uninfected wild type macrophages (WT 
AB WT), GP91phox-/- macrophages and uninfected wild type macrophages (GP91phox AB WT) 
or vice versa.  CFU was measured at 0 and 24 or 48 hours post-addition of naïve macrophages. 
Results are expressed as mean CFU/ml ± SD at the indicated times. *, p < 0.01 comparing CFU 
between groups at 48 h.
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M.tb infection directly induces autophagy in macrophages
 In light of our data showing the involvement of iNOS in co-culture 
conditions, we postulated that in macrophages proceeding towards death with a 
high intracellular burden of M.tb, bacilli may be delivered to a hostile lysosomal
compartment within the cell.  Much recent interest has focused on autophagy as 
a means for macrophages to overcome the arrest of phagosome maturation 
implemented by M.tb.  In prior reports, autophagy in M.tb-infected macrophages 
was activated by stimulation with exogenous rapamycin, interferon-γ or ATP 
[126].  
 We speculated that bacilli in heavily infected macrophages were being 
delivered to autophagosomes despite the absence of exogenous autophagy-
inducing factors. To test that possibility we generated immortalized mouse 
macrophages with stable expression of the autophagosome marker LC3 (also 
referred to as MAP-LC3 for “microtubule associated protein 1 light chain 3”) 
fused to EGFP (enhanced green fluorescent protein, referred to here on out as 
“GFP”) [27].  In the absence of bacilli, green fluorescence was homogenously 
distributed throughout the cytosol of GFP-LC3 macrophages with rare foci of 
aggregation presumably reflecting an expected basal level of autophagosome 
formation (Fig. 2.10).  Induction of autophagy with rapamycin as a positive 
control was reflected by a significant increase in GFP-LC3 aggregation.  A 
similarly strong induction of GFP-LC3 aggregation was observed in macrophages  
infected with viable M.tb at an MOI of 50, which is sufficient to initiate cell death 
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and the antimycobacterial response in co-culture with naïve macrophages.  In 
contrast, GFP-LC3 aggregation was not induced by heat-killed M.tb at MOI 50 or 
by viable M.tb at MOI 10; both conditions previously shown not to result in 
macrophage cell death [2, 127].  The specificity of autophagy induction by viable 
M.tb at high MOI was demonstrated by the failure of viable E. coli to stimulate 
GFP-LC3 aggregation at MOI 50.  These results demonstrated that autophagy 
was specifically induced by a high intracellular burden of M.tb in the absence of 
IFN-γ or other known exogenous factors.
 To confirm that autophagy in heavily infected macrophages delivered 
bacilli to autophagosomes, macrophages were infected with red-fluorescent 
mCherry-M.tb and examined by confocal microscopy.  As shown in Figure 2.11a, 
M.tb was located in vacuoles with circumferential green LC3-GFP fluorescence.  
Co-localization of mCherry-M.tb and LC3-GFP was quantified in confocal images 
of macrophages challenged at low vs. high MOI, confirming a ~60% higher 
frequency in the high MOI macrophage cultures (Fig. 2.12).
 The final stage of phagosome maturation is typically characterized by loss 
of late endosomal markers and fusion with lysosomes.  LAMP1 is a marker 
commonly associated with lysosomal fusion.  To investigate whether LC3 positive 
compartments arising in macrophages with high intracellular burden of M.tb were 
undergoing such maturation, GFP-LC3 expressing cell line macrophages were 
infected with M.tb and subsequently immunostained with anti-LAMP1 antibodies.  
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Figure 2.10: High intracellular burden of M.tb induces LC3 aggregation. GFP-LC3 
expressing macrophages were infected with bacteria for 6 h as indicated below or treated with 
rapamycin before being fixed and examined by confocal microscopy for aggregation of LC3 
indicative of autophagy. Conditions included (A) viable M.tb Erdman (MOI 50), (B) viable M.tb 
Erdman (MOI 10), (C) viable M. smegmatis (MOI 50), (D) rapamycin (25 µg/ml, 3 h), (E) heat-
killed M.tb Erdman (MOI 50), and (F) no infection.  observed by confocal microscopy. MOI 50 
induces LC3 aggregation as strongly as the rapamycin positive control.  MOI 10 and M. 
smegmatis infection (B & C) has no significant increase of LC3 aggregation compared to 
uninfected macrophages (F).  (G) The induction of autophagy was quantified by counting the % 
cells in each group with a number of LC3 aggregates above the median basal level of 5, found in 
untreated, uninfected macrophages. 
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Using pH-stable alexa-fluor conjugated secondary antibodies, we expect that the 
lower pH of the compartment will not affect results [128].  Under these conditions, 
colocalization of LC3 and LAMP1 was evident (Fig. 2.11C).  Mature endosomal 
compartments are also characterized by low pH.  In parallel experiments with 
M.tb-infected GFP-LC3 macrophages, we observed co-localization of LC3 with 
LysoTracker Red DND-99 that partitions to acidified compartments (Fig. 2.11B).  
Collectively, these results indicate that a high intracellular burden of M.tb 
promotes autophagy in macrophages that delivers bacilli to acidified 
autolysosomal compartments where nitric oxide-dependent antimycobacterial 
mechanisms may operate.
 To further investigate the role of autophagy in the co-culture 
antimycobacterial effect, we used siRNA to target specific autophagy related 
genes.  ATG7 is a ubiquitin-like modifying activating (E1-like) enzyme that 
activates LC3 by PE lipidation thus affecting its localization to the 
autophagosome [129].  We then investigated whether or not siRNA knockdown of 
autophagy-related protein 7 (Atg7) would inhibit the antimycobacterial activity in 
the co-culture experiments (Fig. 2.13).  Co-culture conditions consisted of 
macrophages that had been transfected with siRNA targeted against Atg7 or 
control siRNA 72 hours prior to infection of wild type macrophages.  Neither 
control or Atg7 siRNA inhibited the antimicrobial co-culture effect suggesting that 
autophagy is working in conjunction with other cellular mechanisms to decrease 
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the viability of M.tb in the co-culture experiments, but it is not required for 
clearance.
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Figure 2.11:  M.tb localizes to acidified LC3-positive compartments.  (A) GFP-LC3 
expressing macrophages were infected with mCherry-M.tb (MOI 50 or 10, 6 h) and then fixed and 
observed by confocal microscopy. At high MOI there are GFP-LC3 rings surrounding (arrowhead) 
around mCherry-M.tb and co-localization indicated by yellow pixels (arrow) that are not seen in 
macrophages challenged at low MOI. (B) Lysotracker Red DND-99 staining of GFP-LC3 
macrophages infected with M.tb Edrman (MOI 50 or 10, 6 h) demonstrates co-localization of LC3 
and LysoTracker (arrow).  (C)  LAMP1 immunostaining of GFP-LC3 cell line macrophages 
infected with M.tb Erdman (MOI 50 or 10, 5h) demonstrates co-localization of LC3 and lysosomal 
markers (arrowheads).
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Figure 2.11:  M.tb localizes to acidified LC3-positive compartments.  (C)  LAMP1 
immunostaining of GFP-LC3 cell line macrophages infected with M.tb Erdman (MOI 50 or 10, 5h) 
demonstrates co-localization of LC3 and lysosomal markers (arrowheads).
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 Figure 2.12: Co-localization of M.tb with LC3 in infected macrophages. GFP-LC3 expressing 
macrophages were infected with mCherry-M.tb (MOI 50 or 10, 6) and then fixed and observed by 
confocal microscopy. Cells in the MOI 50 (high MOI) and MOI 10 (low MOI) groups where M.tb 
was seen to co-localize with LC3 aggregates (see Fig. 2.11A) were counted. Results are 
expressed at the % cells with co-localization of the total number of cells counted. ****, p < 0.0001 
comparing co-localization between high and low MOI infected groups.
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Figure 2.13: ATG7 siRNA does not inhibit the co-culture antimicrobicidal effect.  (A) Atg7 
was knocked down using Atg7 or control siRNA for 24, 48 and 72 hours.  The effectiveness of the 
knockdown was measured by western blot at each time point.  (B) Atg7 targeting or control 
siRNA knocked down cells were plated 72 hours after knockdown with siRNA.  siRNA treated 
macrophages were infected with M.tb Erdman at MOI 50 for 3 hours.  Infected macrophages then 
were co-cultured with naïve WT macrophages (+ AB) or media alone (no AB).  CFU was 
measured at 0, 48 and 72 h post-addition of naïve macrophages. Results are expressed as mean 
CFU/ml ± SD at the indicated times.
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DISCUSSION
 Macrophage cell death is thought to play a major role in TB pathogenesis 
[130].  Previous studies have shown antimicrobial activity when M.tb-infected 
macrophages with features of apoptosis are co-cultured with naïve macrophages 
[2].  However, when M.tb-infected macrophages become necrotic, for example in 
the context of caseous necrosis in the granuloma, naive macrophages provide no 
antimicrobial effect.  This suggested that efferocytosis of apoptotic bodies 
containing M.tb might enhance antimicrobial activity of naïve macrophages.  
However, in vivo studies using M. marinum infected zebrafish raised doubt by 
demonstrating a role for efferocytosis to spread infection to naïve macrophages 
recruited to granulomas and ultimately to seed distal sites [131].  In the present 
study we demonstrate that the antimicrobial activity against M.tb conferred by 
naïve macrophages in co-culture depends on a lethal intracellular bacillary 
burden in the infected macrophages, but efferocytosis is not required.
 Transwell cultures demonstrated contact-independent crosstalk where an 
afferent signal from infected macrophages, or possibly from M.tb, stimulated an 
efferent signal from naïve macrophages that restricted M.tb replication in the 
former.  The nature of the afferent signal was investigated, with the assumption 
that cytokines or death-related signals such as nucleotides would be involved.  
We found an abundance of IL-1β in co-culture supernatants, and additionally, the 
necessity for IL-1R expression on the naïve macrophage population for 
antimicrobial activity in co-cultures (Fig. 2.4).  M.tb-infected macrophages 
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produced IL-1β and levels were further increased upon exposure to naive 
macrophages.  Giacomini et.al. [132] showed that M.tb infection increases IL-1β 
production in macrophages and recent studies demonstrated that efferocytosis of 
M.tb-infected apoptotic neutrophils by naïve macrophages up-regulates IL-1β 
mRNA expression [133].  The importance of IL-1β in our system is clear, but our 
experiments did not test whether naïve macrophages also produce IL-1β in co-
cultures, nor did they exclude other signals acting synergistically with IL-1β.  
 Supernatants from co-cultures were capable of stimulating antimicrobial 
activity in isolated cultures of M.tb-infected macrophages.  This strongly implied 
that naïve macrophages  produce a soluble factor that augments antimicrobial 
activity in the infected cell population, but an extensive search failed to reveal the 
identity of this factor.  The activity is heat stable, < 3kDa, and resistant to DNase, 
RNase and proteinase K (Fig. 2.7a).  Previous studies have shown that 
nucleotide signaling in macrophages stimulated antimycobacterial mechanisms 
[117, 134] and nucleotides are recognized death-associated molecules.  
However, our studies failed to identify any involvement of ATP or adenosine 
signaling.  Lipid signaling molecules could fit the physical criteria for the efferent 
factor in co-culture supernatants, but inhibiting cyclooxygenase with 
indomethacin had no effect in our system.  Our data have so far excluded a wide 
range of candidates but the identity of the factor that promotes antimycobacterial 
activity in heavily infected macrophages remains unknown at this time.
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 Despite being unable to identify the efferent signal in the co-culture 
system, we were able to gain insight to the antimicrobial mechanisms stimulated 
by crosstalk between naïve and infected macrophages.  Antimicrobial activity is 
expressed exclusively in the pre-necrotic phase of M.tb-induced cell death, when 
few extracellular bacilli were observed by confocal microscopy.  This suggested 
an antimicrobial mechanism operating within the infected macrophages, a 
conclusion supported by our finding that the infected cells must express iNOS in 
order to restrict M.tb.  This cytoplasmic enzyme normally localizes to 
phagosomes containing ingested bacteria to efficiently target its product, nitric 
oxide [23].
 A key feature of M.tb is the capacity to prevent its endosomal 
compartment from progressing through the lysosomal pathway [19, 135]. In 
addition to circumventing exposure to low pH and lysosomal hydrolases, M.tb 
also inhibits iNOS recruitment to phagosomes [24, 136].  Given the requirement 
for iNOS, we questioned whether autophagy provided an alternate mechanism to 
overcome the phagosome biogenesis block by M.tb. Autophagy has been 
described as a defense mechanism against intracellular pathogens including 
M.tb [99, 117, 137, 138].  In addition to the conventional antimicrobial properties 
of acidified phagolysosomes, autophagy results in the generation of neo-
antimicrobial peptides from processing of ubiquinated cytosolic proteins that are 
capable of killing M.tb [139].  Published studies have so far relied on starvation or 
exogenous agents such as IFNγ or rapamycin to induce autophagy in M.tb-
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infected macrophages.  We found that M.tb infection can directly induce 
autophagy in macrophages without any requirement for starvation or exogenous 
factors.  This occurs specifically in the context of a lethal intracellular bacillary 
burden and presumably reflects a stress response in cells committed to death.  
The specificity of this response to a high intracellular burden of viable M.tb was 
shown by the lack of autophagy induction by heat-killed M.tb at high MOI, viable 
M.tb at low MOI, viable M. smegmatis at high MOI or viable E. coli at high MOI.  
In the absence of co-culture with naïve macrophages, this autophagic response 
does not appear to significantly reduce bacillary viability.  That may be due a 
relatively brief time for exposure of bacilli to hostile conditions before the infected 
cell progresses to a necrotic state [127].  The soluble factor promoting iNOS-
dependent antimicrobial activity in these dying cells could act in any of several 
ways.  It might accelerate delivery of M.tb to autolysosomes, it might amplify 
iNOS enzymatic activity or localization to mycobacterial vacuoles, it might amplify 
autophagy-specific antimicrobial mechanisms [139], or it might delay 
macrophage necrosis and thereby prolong the exposure of bacilli to degradative 
processes within intact autolysosomes.
In conclusion, we studied interactions between M.tb-infected and naïve 
macrophages which model events in pulmonary TB where alveolar macrophages 
initially infected by inhaled M.tb become surrounded by an excess of recruited, 
naïve macrophages before the expression of adaptive immunity that restricts 
bacillary replication [108].  This models approximately 7 days post infection, at 
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which point M.tb has had time to undergo several doublings.  We recently 
showed that in this early, innate phase of TB defense relatively unrestricted 
replication leads to high intracellular bacillary loads in vivo [127], which results in 
macrophage necrosis. Since virulent M.tb inhibits macrophage apoptosis, but 
ultimately triggers necrosis at high bacillary loads it is unlikely that antimicrobial 
mechanisms dependent on efferocytosis play a major role in TB defense.  Our 
data reveal a 2-way interaction where M.tb-infected macrophages committed to 
cell death, produce a signal that causes naïve macrophages to respond by 
producing a factor which promotes iNOS-dependent inhibition of M.tb replication 
in autolysosomes.  While the afferent signal requires IL-1β, additional co-factors 
may be involved.  The identity of the efferent signal is presently unknown but our 
data permit a focused search by excluding DNA, RNA, proteins and molecules > 
3 kDa.  The co-culture antimycobacterial effect we describe here may represent a 
previously unrecognized innate immunological defense mechanism that may limit 
the maximal replicative potential of M.tb prior to the expression of adaptive 
immunity in the newly infected host or alternatively mimic late stage reactivated 
TB disease.  
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MATERIALS AND METHODS
Ethics statement
 Experiments with animals were conducted according to the National 
Institutes of Health guidelines for housing and care of laboratory animals under 
protocols approved by the Institutional Animal Care and Use Committee (A-1429) 
and the Institutional Biosafety Committee (I-161) at The University of 
Massachusetts Medical School.  
Reagents  
 Autophagy inhibitor 3-methyladenine, the non-selective P2X7 receptor 
agonist 5’-N-ethylcarboxamidoadenosine (NECA), ribonucelase A1, proteinase K 
(from Tritirachium album), Atg7 antibody, LAMP-1 antibody, anti-actin antibody 
and the cyclooxygenase inhibitor indomethacin were purchased from Sigma 
Aldrich.  Secondary antibody Alexa Fluor 647 goat-anti-rabbit IgG detection for 
LAMP-1 immunofluorescence was purchased from Molecular Probes.  LEAF 
purified anti-mouse IL-1α and IL-1β neutralizing antibodies were purchased from 
BioLegend.  The mTOR inhibitor rapamycin was purchased from Cell Signaling. 
TURBO DNase was purchased from Ambion. Centrifugal filter devices used for 
size fractionation based on Stoke’s radius were purchased from Millipore.  E.coli-
derived recombinant murine IL-1α and IL-1β were purchased from R&D systems.  
HRP-conjugated anti Rabbit antibody, goat-anti-rabbit IgG isotype control for IL-1 
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neutralization experiments, and West Pico reagent were purchased from Pierce.  
Non-reversible COX-2 inhibitor Aspirin was purchased from Alexis Biochemicals.
Cell culture and mice  
 Immortalized cell lines originating from murine bone-marrow macrophages 
were made from C57/BL6 wild type mice, iNOS-/- mice (Jackson Labs), 
GP91phox -/- mice (gift from Dr. P. Newburger, University of Massachusetts 
Medical School), IL-1R-/- mice (gift of Dr. K. Fitzgerald, University of 
Massachusetts Medical School) using a J2 transforming retrovirus previously 
described [140, 141].  P2X7R-/- mice were provided by Dr. R. Ingalls (Boston 
University School of Medicine) and Dr. A. Hise (Case Western Reserve 
University), and A2a R-/- mice were kindly provided by Dr. J.F. Chen (Boston 
University School of Medicine). Creation of the GFP-LC3 vector and 
macrophages are described by Harris et al. [27]. Cell lines were maintained in 
DMEM medium (Invitrogen Life Technologies) supplemented with 10% FBS 
(BioWhittaker), 100U/mL penicillin, 100 mg/mL streptomycin and 2mM glutamine 
and 10% L-929 conditioned media, made in-house, is added for culturing bone 
marrow derived macrophages.  
Bacterial strains and infections 
 M.tb Erdman, used for all experiments unless otherwise indicated was 
obtained from Trudeau Institute.  M. smegmatis mc2155 was purchased from 
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ATCC. mCherry-M.tb, a generous gift from Dr. C. Sassetti (University of 
Massachusetts Medical School), was synthesized and codon-optimized with the 
mCherry open reading frame cloned into a pAL5000 based multicopy plasmid 
under the control of an optimized E. coli promoter in the M.tb H37Rv background. 
Bacteria were cultured in roller bottles containing Middlebrook 7H9 broth to OD600 
of 0.7, washed twice in PBS and resuspended in DMEM medium supplemented 
with 10% FBS and 2mM glutamine at 1.5 - 2x108 bacteria per mL. Stocks of 
bacteria were frozen immediately at -80oC. Heat killed M.tb was generated by 
boiling bacteria at 100 oC for 30 min.  
To infect cells, an aliquot of M.tb culture was thawed and dispersed with 
water bath sonicator (Branson Ultrasonics) for 90 sec at room temperature.  
Cultures were allowed to settle for 20 min to remove clumped bacteria followed 
by infecting macrophages at MOI 10 or 50 for 3 h at 37 oC, 5% CO2. Infected 
macrophages were washed twice with DMEM and incubated for an additional 1h.  
CFU was measured at 0, 24, 48 or 72 h after the addition of the naïve 
macrophages by incubating the cells in 0.05% Tween 20 in water for 5 min at 
room temperature. Cultures were agitated by pipetting and serial diluted in 0.05% 
Tween 80 in PBS then plated onto Middlebrook 7H11 agar plates.  Plates were 
incubated at 37 oC until colonies were counted 16 and 21 days after plating.
MOI was verified by fluorescent microscopy after staining M.tb with 
auramine-O (auramine).  Stock solution of auramine is 1% auramine in methanol. 
Working auramine solution is 0.1% auramine and 33.3% phenol in water.  
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Samples are stained with working solution of auramine for 20 minutes at room 
temperature.  1% acid alcohol solution (40% denatured alcohol, 10% HCl in 
water) is used to counter-stain samples.  Counterstain for 3 minutes after 
auramine staining without rinsing samples in between steps.  After counterstain, 
wash 3x with PBS then slide was mounted with no-fade solution and imaged by 
fluorescent confocal microscopy.  Approximate number of M.tb bacilli per were 
assessed in infection batches for add-back experiments.
Co-culture experiments  
 2 x105  macrophages were incubated for 1 h in 24-well polystyrene tissue 
culture plates (Nalge Nunc International) and then were infected as described 
above.  At 3 h post-infection, an equal number of naïve macrophages were 
added either directly to wells containing infected macrophages, or to 0.4 µm 
pore-size, polycarbonate Transwell® inserts (Corning Inc.). Co-cultures were 
incubated for various time points before lysis of infected cells and plating for 
CFU. In supernatant transfer experiments, supernatants were collected from co-
cultures of naïve and M.tb-infected macrophages 3 h after the naïve cells were 
added. Supernants were filter-sterilized (0.22 µm) and then added to 
macrophages that had been infected as described above.
Co-Culture Experiments with Inhibitors
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 Co-culture experiments were set up as described above.  In the NECA 
experiments, the adenosine receptor agonist was present for the duration of the 
co-culture.  For the aspirin experiments, infected  or naive macrophages were 
pre-treated with 20mM aspirin  for 15 minutes prior to being plated before 
infection or before being added to infected macrophages.  For indomethacin 
experiments, cells were pre-incubated with 10 µM indomethacin for 3 hours prior 
to infection.  In one group, indomethacin was washed out of the co-culture, in the 
other group, due to the reversible effects of the drug, 10µm indomethacin 
remained for the duration of the experiment.  
Co-Culture Experiments IL-1 Neutralizing Antibodies
 Co-culture experiments were set up as described above.  At the time of 
the addition of the naïve cell line macrophages to the infected ones, 50 µg/mL of 
neutralizing antibodies or IgG isotype control antibody was also added.  
Antibodies remained in the co-culture until the time at which CFU was measured.
Multiplex  
 Supernatants from macrophages infected at MOI 50 and supernatants 
from high MOI co-cultures were collected at 3 h post-addition of naïve 
macrophages or 7 h post-infection.  Supernatants were passed through a 0.22 
µm pore size syringe filter then frozen at -80 oC until shipped for multiplex 
analysis (Aushon Biosystems).
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Macrophage staining and fluorescent laser scanning confocal microscopy  
 Macrophages were stained with cholera toxin subunit B conjugates 488 or 
647 (Molecular Probes) at 4 oC for 30 min and then washed three times with 
DMEM.  For confocal microscopy, cells were then plated at 106 cells per 35mm 
glass bottom plate with 10 mm glass No. 1.5 thickness (MatTek). After infection 
and/or co-culturing, contents of plates were fixed with 4% paraformaldehyde in 
PBS for 30 min then washed three times with PBS. Cells were imaged using a 
63x objective at room temperature with a SP2 AOBS confocal laser scanning 
microscope (Leica Microsystems) running LCS software (Leica Microsystems).
Lysotracker staining 
 GFP-LC3 expressing macrophages were infected at MOI 50 for 2 h then 
washed twice with DMEM and incubated 2 h further. 50nM lysotracker red 
DND-99 (Invitrogen) was added to infected macrophages for 20 min at room 
temperature. Cultures were then washed three times with PBS and fixed with 4% 
paraformaldehyde in PBS for 30 min.  Before imaging, fixed cells were washed 
three times with PBS.
LAMP-1 Immunostaining 
 GFP-LC3 expressing cell line macrophages were infected at MOI 50 for 3 
h then washed twice with DMEM and incubated 2 h further.  Cultures were then 
washed three times with PBS and fixed with 4% paraformaldehyde in PBS for 30 
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min. then permeabilized with 0.1% Triton X-100 in PBS for 10 min. and blocked 
in blocking buffer (10% goat serum in PBS with 1% BSA and 0.1% Triton X-100) 
for one hour.  Cells were then stained 1:200 with anti-LAMP1 antibodies (Sigma) 
for one hour in blocking buffer.  After washing 5x with PBS, cells were stained 
with anti-Rabbit secondary antibody conjugated to Alexa Fluor 647 (Molecular 
Probes) for 1h.  Cells were then washed 5x with PBS and mounted as described 
above for confocal microscopy.
Quantifying cell-cell contact  
 After confocal imaging, broad fields of cells were assessed for interactions 
indicative of efferocytosis. While complete engulfment of infected macrophages 
by uninfected macrophages was rarely observed, the images revealed frequent 
cell-cell interactions with a distinct directionality of cell contact having the 
appearance of frustrated efferocytosis. To quantify the direction of these contacts 
a “positive” efferocytosis interaction was defined as pedestal formation or 
incomplete engulfment of one cell by another. A “negative” interaction was one 
where two cells in contact showed no synapse or pedestal formation and no 
extension of membrane from one cell partially surrounding another. Results are 
expressed as % positive interactions vs. % negative interactions. 
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siRNA gene silencing 
 25mer Stealth siRNA RNA oligonucleotides for silencing mouse ATG-7 
were purchased from Invitrogen. The sense strand of the siRNA duplex consisted 
of a 25 nucleotide target sequence (5’-caa uga ugu ggu ggc ucc agg aga u-3’) 
and the antisense strand was composed of nucleotides complementary to the 
target sequence. For a negative control, scrambled 25mer stealth siRNA with 
medium G-C content were used. Two million macrophages were transfected with 
1 uM of siRNA using Neon (Invitrogen) according to the manufacturer’s 
instructions. The electromechanical condition for transfection was pulse voltage 
1650 V, pulse width 20, and pulse number1. The efficacy of Atg-7 silencing was 
confirmed by Western blot.
SDS-polyacrylamide Gel Electrophoresis and Western Blotting
 Lysates were made from siRNA-knocked down cells by incubating cells in 
M-PER Mammalian Protein Extraction Reagent (Thermo Scientific) by 
manufacturers instruction shaking gently for 5 minutes.  Cell debris was pelletted 
by centrifugation at 14,000 x g for 15 minutes.  Supernatants were frozen at 
-80℃ until used for gel electrophoresis. 
 For resolving protein by gel electrophoresis, a 10% SDS-polyacrylamide 
gel was made with a 6% acrylamide stacking gel.  100µg of protein was boiled at 
100℃ for 5 minutes in Laemmili Buffer and loaded onto the gel.  The gel ran for 
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90 minutes at 155 V.  Proteins were transferred onto PVDF membrane at 250 
mA for one hour.  
 After transfer, non-specific antibody binding was blocked using 5% non-fat 
dried milk in TBST for one hour.  Membrane was kept rocking at 20℃ overnight 
in primary antibody (1:2500 in 5% non-fat dried milk in TBST).  The next day, the 
membrane was washed 3x in TBST for 5 minutes each then incubated in 
secondary HRP-conjugated detection antibody (1:1000) for 4 hours at room 
temperature.  After 3x 5 minute washes with TBST, membrane was developed 
using West Pico reagent (Pierce).  Kodak film was exposed to blotted membrane 
for 10 seconds and developed.
Quantifying the Number of Colony Forming Units (CFU) per mL  
 CFU                  # of colonies on plate--------  =  ---------------------------------------------------------  mL       (dilution factor)(volume inoculated in mL)
Statistics  
 Differences between groups at the same time-point were assessed by 
unpaired t-test using GraphPad Prism. Values of p ≤ 0.05 were considered to be 
statistically significant.
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PREFACE to Chapter III
The first publication using GFP-LC3 expressing macrophage cell line, listed 
below, was the debut of the GFP-LC3 expressing immortalized macrophage cell 
line made by Michelle Hartman with immense technical assistance from Brian 
Monks and Veit Hornung.
Dr. James Harris at Trinity College Dublin thoroughly tested the GFP-LC3 cell 
line and generated all data and images for Figures 3.5 and 3.6 of this 
dissertation.
Citation:
James Harris, Michelle Hartman, Caitrionna Roche, Shijuan G. Zeng, Amy 
O’Shea, Fiona A. Sharp, Eimear M. Lambe, Emma M. Creagh, Douglas T. 
Golenbock, Jurg Tschopp, Hardy Kornfeld, Katherine A. Fitzgerald & Ed C. 
Lavelle.  Autophagy controls IL-1β secretion by targeting pro-IL-1β for 
degradation.  Journal of Biological Chemistry.  2011.  286: 9587-9597.
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CHAPTER III: Construction of a GFP-LC3 Expressing 
Macrophage Cell Line
Abstract
 Autophagy is widely accepted to be a mechanism that macrophages use 
to rid themselves of Mycobacterium tuberculosis.  We sought to determine 
whether autophagy resulted in a high intracellular bacterial burden with M.tb and 
also whether or not it contributed to the antimycobacterial effects observed in the 
co-culture experiments.  To determine the role of autophagy in this context, it was 
critical to create cells that allowed us to visualize the localization of M.tb within 
the infected macrophage and additionally provide a simple assay to determine 
whether or not autophagy was stimulated under various conditions.  This chapter 
describes the 8-month process of creating such a cell line.
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Introduction
 Though macroautophagy, here on out referred to as autophagy, is most 
widely recognized as a cellular homeostatic process that enables cells to 
degrade and recycle their contents, it is clear that it also plays a significant role in 
eliminating some intracellular pathogens, a process alternatively referred to as 
xenophagy  [143-146]  Pathogen-induced autophagy appears to be TOR-
independent [147].    
 The role of autophagy in eliminating intracellular M.tb was initially 
demonstrated by Guitierrez et. al. [99].  It was shown that upon stimulating 
autophagy in M.tb-infected macrophages by amino acid starvation, there was 
increased co-localization of the autophagosome marker LC3 to the 
mycobacterial-containing phagosome, coupled with increased acidification of the 
compartment.  Singh et. al. reported that autophagy related to the inhibition of 
M.tb replication is associated with interferon (IFN)-ϒ and its effector Irgm1 (the 
IFN-inducible immunity related GTPase family M member 1, formerly referred to 
as LRG-47)  [101]  They provide data suggesting that Irgm1 increases 
phosphatidylinositol-3-kinase (PI3K) accumulation in the M.tb-containing 
autophagosome, resulting in enhanced autophagolysosomal maturation.  Since 
the trademark of M.tb infection is its phagosome-lysosome fusion block, allowing 
the pathogen to evade cellular destruction [148-150], the demonstration of 
autophagy as a mechanism for the macrophage to override this phagosome 
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maturation block was novel and opened the door to new studies focusing on new 
innate immune pathways involved in the elimination of M.tb.
 The precise function and mechanism of every autophagy related protein is 
unknown.  However, what is more widely understood is which proteins are 
located on the autophagosomal membrane at different times.  Yeast autophagy-
related (ATG) protein 8, a soluble cytoplasmic protein that associates with the 
phagophore after being covalently conjugated with phosphatidylethanolamine 
(PE) is recruited to the autophagosome early on and remains associated with it 
into maturity.  The mammalian orthologs of ATG8 include GABARAP, GATE-16 
and MAP-LC3 (or microtubule-associated protein 1 light chain 3- now referred to 
as “LC3”).  All of these orthologs are processed by a cysteine protease ATG4, 
followed by activation by ATG7 and leading to lipidation by PE.  However, only 
LC3 is observed in pre-autophagosomal structures as well as mature 
autophagosomes.  Though the precise function of LC3 is unknown, it is 
understood to be regulated by phosphorylation [151] and is cleaved and 
processed at the induction of autophagy [152].  After its cleavage, LC3 
specifically labels the growing phagophore and mature autophagosomes [142, 
153].  The major pathways promoting the induction of autophagy converge on the 
cleavage and lipidation of LC3, which allows for its conjugation to phospholipids 
and is critical for the formation of autophagosomes and cargo recognition [94, 
154, 155]  The role of LC3 in the induction of autophagy and its association with 
mature autophagosomes make it a useful tool to investigate the role of 
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autophagy in eukaryotic systems.  In this chapter, I describe the development of 
a macrophage cell line that expresses the fusion protein EGFP-LC3, for the 
purpose of investigating the role of autophagy in the context of M.tb infection.  
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Results
Development of a GFP-LC3 expressing immortalized macrophage cell line
 Before control experiments revealed to us that engulfment of infected, 
apoptotic bodies/macrophages (efferocytosis) was not necessary for the co-
culture antimycobacterial effect, we started making a fluorescent cell line to test 
the hypothesis that autophagy was involved in the destruction of the apoptotic 
bodies.  Though our studies demonstrated that efferocytosis of infected cells was 
not involved, much recent interest has focused on autophagy as a means for 
macrophages to overcome phagosome maturation arrest in M.tb-infected 
macrophages.  We speculated that bacilli in heavily infected macrophages were 
being delivered to a hostile lysosomal compartment within the cell via 
autophagosomes.  To test that possibility, we generated immortalized mouse 
macrophages with stable expression of the autophagosome marker LC3 fused to 
GFP. [27]   
 The pEGFP-LC3m plasmid was created by cloning Rattus norvegicus 
microtubule-associated proteins 1A and 1B light chain 3 subunit (LC3)
into the multiple cloning sight (MCS) 3‘ of the EGFP coding sequence (Figure 
3.1).  LC3 was cloned into the pEGFP-C1 plasmid in a manner that both proteins 
were in the same reading frame [142].  This plasmid was obtained from Dr. 
Noboru Mizushima at Tokyo Medical and Dental University (Tokyo, Japan) via Dr. 
Stephen Doxsey at UMass Medical School (Worcester, MA).
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Figure 3.1: Map of pEGFP-LC3m construct.  (A) Original pEGFP-C1 plasmid map containing 
EGFP (dark orange) and a kanamycin resistance cassette (light orange).  (B) Rattus norvegicus 
LC3 cDNA was cloned into the MCS of pEGFP-C1 plasmid using BamH1 and Sal1.
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 Plasmid DNA is notoriously difficult to transfect into macrophages [156].  
To circumvent this difficulty, a retroviral construct was made to generate virion 
needed to transduce macrophages to express the vector expressing the EGFP-
LC3 construct.  pRP vector, a generous gift from Dr. D. Golenbock, was modified 
from a pcDNA3 backbone (Invitrogen) by removal of the Neomycin resistance 
cassette and SV40.  The SV40 origin was retained however so that the vector 
could replicate in HEK 293T-cells.  pRP::EGFP-LC3 was constructed in the 
following way: EGFP-LC3 was double digested out of the pEGFP-LC3m plasmid 
with restriction enzymes AgeI (New England Biolabs) and PspOMI (Fermentas).   
The viral vector pRP cut with NotI and AgeI.  Both the vector and the insert were 
gel purified (Fig. 3.2a) and directly ligated into into the multiple cloning site (MCS) 
where expression of the construct is constitutively expressed by the 
cytomegalovirus (CMV) promoter.  Ligated construct was transformed into XL1 
Blue E.coli and cultured in Luria-Bertani (LB) broth containing ampicillin for 
generating large amounts of plasmid copies.  pRP-GFP-LC3 was then verified by 
restriction digestion (Fig. 3.2b). 
 Complete retrovirus expressing the construct was generated in HEK’s by 
transfecting them using Transit® transfection reagent with EGFPLC3::pRP along 
with two separate plasmids expressing Gag/Pol and VSVG.  Three days later 
retrovirus was isolated from supernatant of the transduced HEK cells.  To 
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Figure 3.2: Verification of pRP vector and EGFP-LC3 insert before and after ligation. (A) 
EGFP-LC3 was double digested using  out of its original vector pEGFP-LC3m.  pRP was also 
digested.  Digestion products were gel purified to optimize ligation reaction.  (B) EGFP-LC3 was 
directly ligated into prepared pRP vector using T4 ligase reaction without any PCR modification of 
the insert.  After ligation, plasmid was electroporated into XL1 Blue E. coli.  Several different XL1 
Blue E. coli colonies were tested for expression of the vector, lanes 1-3.  Plasmid was digested 
with EcoR1 to verify insertion of construct into pRP vector.  Band at approximately 1Kb signifies 
proper insertion of EGFP-LC3 into pRP. 
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transduce the vector into wild type cell line macrophages, the virus-containing 
supernatant was titrated to 30%, 20%, 10%, 5% and 2.5% of the medium and 
added directly to the macrophages plated at 70% confluency.  48 hours post-
transduction, cells expressing the plasmid were selected for with media 
containing 5µg/mL puromycin and 30% FBS. One week later, colonies 
expressing the construct were isolated and expanded under constant selection 
with 5µg/mL puromycin.  The expanded macrophages were sorted (Fig. 3.3) to 
remove any macrophages not expressing the construct by our FACS 
(Fluorescence-Activated Cell Sorting) core facility at UMass Medical School 
FACS CORE facility.  FACS-sorted macrophages were grown in bulk and frozen 
at -80ºC in 1mL aliquots.  
Verifying function of GFP-LC3 expressing Macrophages
 To verify that the newly-made cell line were performing as expected, cells 
were treated with 25 µg/mL rapamycin, a pharmacological inducer of autophagy, 
and an equal volume of its carrier control ethanol, for 3 hours.  Treated EGFP-
LC3 cell line macrophages were then fixed and imaged by confocal microscopy 
to assess whether the cells behaved normally.  Figure 3.4 shows that carrier 
control treated macrophages have a diffuse GFP pattern throughout the 
cytoplasm yet cells treated with rapamycin clearly have an increased amount of 
GFP puncta which represent the aggregation of LC3, presumably to the 
phagophore and autphagosome membranes.  
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 Figure 3.3 Linear map of pRP-EGFP-LC3 plasmid.  EGFP-LC3 is inserted into the pRP viral 
vector so that it is between the 5’ and 3’ UTR to ensure packaging into virion head and is 
downstream of the CMV promoter for constitutive expression.
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Figure 3.4 Control testing EGFP-LC3 cell line macrophages.  Macrophages containing the 
pRP-GFP-LC3 construct have a diffuse fluorescent green appearance.  GFP-LC3 macrophages 
were treated with (A) ethanol only as a carrier control to rapamycin treated macrophages and (B) 
Rapamycin (25 µg/mL). Control macrophages have more GFP in cytoplasm compared to 
rapamycin-treated group which has increased GFP puncta confirming the validity of the cell line.
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 Furthermore, to ensure that GFP puncta were not resulting from random 
clustering of GFP protein in the cell, collaborator James Harris (Trinity College 
Dublin) stained cells with antibody against LC3B and analyzed co-localization of
LC3 with GFP by confocal microscopy  After stimulating autophagy with LPS  for 
18 hours, cells were fixed, permeablized and stained with LC3B primary antibody, 
followed by secondary antibody staining with Alexa Fluor 568 conjugated goat 
anti-rabbit antibody.  There is clear co-localization of the antibody with the GFP-
puncta suggesting that clusters observed are LC3 aggregations (Fig. 3.5). 
 LPS stimulates autophagy via a Toll-interleukin receptor domain-
containing adaptor-inducing interferon β (TRIF)-dependent, MyD88-independent 
TLR-4 signaling resulting in a p38-mitogen activated protein kinase acting 
downstream [157].  Induction of autophagy by IFN ϒ is dependent on  To verify 
that the modification of the macrophages by expression of the pRP-GFP-LC3 
vector did not alter the cells response to autophagy stimuli, the cells were treated 
with known stimuli of autophagy and assessed for GFP-LC3 puncta formation by 
confocal microscopy (Fig 3.6b).  This experiment was carried out by Dr. James 
Harris of Trinity College Dublin.  LC3 macrophages were stimulated with LPS or 
IFN-γ for 18 hours then observed by confocal microscopy and the number of 
LC3-positive puncta were counted in at least 100 cells per group Figure 3.6a).  
The significant increase in LC3 puncta in LPS and IFN-γ treated cells suggests 
that the cells respond normally, in the context of autophagy, to TLR-4 and IFN-γ 
stimulation.
80
Figure 3.5: Anti-LC3b antibodies co-localize with puncta in GFP-LC3 cell line 
macrophages.  Characterization of GFP-LC3 cell line macrophages by confocal microscopy.  
Locality of LC3 antibody staining (red) and GFP-LC3 protein expression in macrophages (green) 
was assessed to ensure that GFP puncta within the macrophages reflected LC3 puncta.  Co-
localization of antibody labeling with GFP-puncta within the cell is demonstrated by overlay of 
green and red stains, yielding a yellow appearance.
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Figure 3.6: Number of LC3-positive vesicles in cells increases with LPS and IFN-γ 
treatment.  LPS and IFN-γ were used to verify that the GFP-LC3 cell line macrophages 
responded properly to known stimuli of autophagy.  Cells were treated with 100 ng/mL LPS or 10 
ng/mL IFN-γ for 18 hours then LC3 puncta were counted (A) after imaging by confocal 
microscopy (B).  *p ≤ 0.01 by one-way ANOVA with Tukey’s post-test. 
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Discussion
 The appearance of distinct LC3 puncta following stimulation of autophagy 
suggests that our cell line is useful for detecting upstream events of autophagy 
since the translocation of LC3 from the cytosol to the autophagosomal 
membrane is the point at which various autophagic pathways converge [94].  
However, one limit of the cells may be that the maximum percentage of cells 
expressing 5 or more puncta with induction by rapamycin is only 30% (Fig. 
2.10g).  Though there is a 15% difference between untreated and rapamycin-
induced groups, the range is limited.  However, without immunoblotting for 
endogenous LC3 it is impossible to exclude the possibility that a greater 
difference exists between the two groups.
One possible problem with using labeled proteins in transiently transfected 
cells, specifically GFP-LC3, is that this method commonly causes aggregation of 
the protein and this event is almost impossible to be differentiated from the 
induction of autophagy [158].  However, strong co-localization of immunoblotting 
for LC3B with GFP-LC3 suggests that this effect is minimized in the cell line.  
Furthermore, in untreated GFP-LC3 expressing macrophages, on average, there 
were less than five GFP-LC3 puncta per cell.  This is no more than one would 
expect to see due to the ongoing activity of autophagy in cells for housekeeping 
duties.  It is also likely that the GFP-LC3 labeled protein behaves differently from 
endogenous LC3 in terms of trafficking, size of vacuole and additionally rate of 
maturation due to any changes in the kinetics of lysosome fusion events.  
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 The major advantage in using an EGFP-LC3 expressing cell line is that 
you can visualize the activation and maturation of autophagosomes by following 
LC3.  Alternative methods such as immunoblotting are viable alternatives to 
using the GFP-LC3 cell line, but are more cumbersome and not as convenient.  
When working with antibodies to label fixed cells, it is more difficult to be certain 
that the protein that the antibody is binding to is specific.  The cell line also 
enables real-time imaging, which is critical for looking at cellular processes, like 
autophagy, that are dynamic and often rapidly induced.  Other methods for 
simply detecting the activation of autophagy, such as western blotting, though 
useful for measuring specific changes to LC3 that are trademark to autophagy, 
do not allow for visualizing what is inside the autophagosomal compartments 
themselves.  Thus, these GFP-LC3-expressing macrophages represent an 
extremely powerful tool for dissecting autophagy-dependent processes. (Harris 
2010 JBC)
 Additionally, LC3 is recycled quickly by removal from PE by the ATG4 
protease (Kirisako 2000) and becomes trapped in the autophagosome and 
degraded after lysosomal fusion with the autophagosome.  Therefore, mature 
autophagosomes lack in-tact LC3, thus indicating that a separate marker is 
needed to study those structures.  However, regardless of the constant recycling 
of LC3, GFP is quickly denatured in acidified compartments, suggesting an 
alternative fluorophore might be preferred for following autophagy more closely.  
Proteins such as RFP and mCherry are more stable and should be considered in 
84
the event of making a construct for a human macrophage cell line, such as 
human acute monocytic leukemia cell line (THP-1) cells.
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Materials and Methods
Reagents  
 ATG7 antibody, LC3B antibody, anti-actin antibody, and bisBenzamide H 
(Hoechst) 33258 were purchased from Sigma Aldrich.  Alexa Fluor 568 goat anti-
rabbit antibody was purchased from Molecular Probes/Invitrogen.  The mTOR 
inhibitor Rapamycin was purchased from Cell Signaling.  LPS and IFNϒ for 
stimulating GFP-LC3 cell line was obtained from Biosera (Ringmer, East Sussex, 
UK).  HRP-conjugated anti Rabbit antibody and West Pico reagent were 
purchased from Pierce. 
Cell culture and mice  
 Immortalized murine macrophage cell lines derived from C57/BL6 wild 
type mice was a generous gift from Dr. D. Golenbock (University of 
Massachusetts Medical School) [20, 21].  Creation of the GFP-LC3 vector and 
macrophages are described by Harris et al. [18]. Cell lines were maintained in 
DMEM medium (Invitrogen Life Technologies) supplemented with 10% FBS 
(BioWhittaker), 100U/mL penicillin, 100 mg/mL streptomycin and 2mM glutamine 
and 10% L-929 conditioned media, made in-house, is added for culturing bone 
marrow derived macrophages.  
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Plasmids and constructs
 LC3 cDNA came from Dr. T. Yoshimori (Osaka University) and Dr. N. 
Mizushima (Tokyo Medical and Dental University).  The GFP-LC3 plasmid [13] 
was a generous gift from Dr. S. Doxsey (University of Massachusetts Medical 
School).  pRP viral vector backbone was a gift from Dr. D. Golenbock (University 
of Massachusetts Medical School).  
 Immortalized bone marrow-derived macrophages stably expressing 
EGFP-LC3 (GFP-LC3) were generated by directly cutting EGFP-LC3 out of the 
pEGFP-C1 vector (22) and inserting it into the multiple cloning site of the 
retroviral pRP vector (23) using restriction endonucleases NotI and AgeI.  
Retrovirus carrying the EGFP-LC3 construct was made in HEK cells by 
transfection with EGFP-LC3::pRP, along with plasmids expressing Gag/Pol and 
VSVG using TransIT® transfection reagent (Mirus, Madison, WI, USA). Three 
days later retrovirus was isolated from supernatant of the HEK cells and used to 
transduce the EGFP-LC3 construct into wild type C57/Bl6 immortalized WT 
macrophages. 48 h post-transduction, cells expressing the plasmid were 
selected for using media containing 10 µg/mL Puromycin.  One week later, 
colonies expressing the construct were isolated based on GFP fluorescence by 
flow cytometry and expanded under constant selection with 10 µg/mL Puromycin.  
Cells were grown in DMEM medium (Invitrogen Life Technologies) supplemented 
with 10% FBS (BioWhittaker), 100U/mL penicillin, 100 mg/mL streptomycin and 
2mM glutamine.
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Verificaiton of GFP-LC3 function by confocal microscopy  
 For testing induction of autophagy by rapamycin treatment, cells were 
plated at 106 cells per 35mm glass bottom plate with 10 mm glass No. 1.5 
thickness (MatTek).  After treatment with rapamycin (25 ug/mL) or ethanol (carrier 
control) for 3 hours, cells were fixed with 4% paraformaldehyde in PBS for 30 min 
then washed three times with PBS. Cells were imaged using a 63x objective at 
room temperature with a SP2 AOBS confocal laser scanning microscope (Leica 
Microsystems) running LCS software (Leica Microsystems).
 To verify LC3 antibody staining co-localized with GFP-LC3 puncta in 
autophagy-induced macrophages, GFP-LC3 macrophages were stimulated with 
LPS (100 ng/mL) or IFNϒ (10 ng/mL) for 18 h to induce autophagy.  Cells were 
fixed with 2% paraformaldehyde (in PBS) for 30 min at room temperature, then 
permeabilized with 0.1% Triton X-100 (in PBS) for 10 min.  Before antibody 
staining, permeablized cells were blocked with 3% BSA/5% goat serum (in PBS) 
for 1 h to minimize non-specific binding of the LC3 antibody to other proteins.  
Cells were then stained with primary antibody, rabbit anti-LC3B (Sigma) for 1 h at 
1/200 dilution (approximately 5 µg/ml) in blocking buffer.  After 5 washes with 
PBS, secondary antibody, Alexa Fluor 568 goat anti-rabbit (Molecular Probes/
Invitrogen), was applied for 1 h at 1/500 in PBS.  Cells were washed twice with 
PBS then incubated with 10 ug/ml bisBenzamide H 33258 (Hoechst 33258, 
Sigma) for 5 minutes then washed 3 times with PBS and mounted with Dako 
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Fluorescent mounting medium.  Images were taken on an Olympus FV10 
confocal microscope with FV10-ASW software.
Agarose Gel Electrophoresis
 DNA preparations of constructs were isolated from XL1-Blue E. coli by 
mini-prep procedure (Qiagen).  Briefly, E. coli, containing various plasmids, was 
grown in LB medium containing Kanamycin (pEGFP-LC3m plasmid) or Ampicillin 
(pRP-GFP-LC3 plasmid) to ensure that all replicating bacterium contained the 
plasmid of interest.  Bacterium were re-suspended and lysed under alkaline 
conditions first re-suspending pelleted bacterium in P1 buffer (50 mM Tris-Cl, pH 
8.0, 10 mM EDTA, 100 ug/mL RNAse A, pH 9) to ensure precipitation of all DNA 
with RNAse present to ensure collection of desired plasmid DNA and not RNA’s.  
Followed by addition of a 5 M potassium acetate solution (P2 buffer: 200 mM 
NaOH, 1% SDS, pH 8) which neutralizes NaOH allowing small plasmids to 
remain soluble while genomic DNA, but not plasmid DNA, to precipitate out of the 
lysis solution.  After 5 minutes of incubating, N3 buffer (proprietary buffer 
containing potassium acetate, pH 4.8) is added, which allows for precipitation of 
proteins out of the solution.  Precipitates are removed from supernatant by 
centrifugation for 10 minutes at 13,000 rpm.  Supernatants are then applied to a 
spin column containing a silica-gel-membrane, which binds small DNA’s.  The 
column is then washed with PE (10 mM Tris-HCl, 80% EtOH, pH 7.5) and PB (5 
M Gu-HCl, 10 mM Tris-HCl 30% EtOH, pH 6.6) buffers.  After residual wash 
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buffer is removed, plasmid DNA is eluted in 50-100 µL of elution buffer (1.25 M 
NaCl, 50 mM Tris-HCl pH 8.5, 15% isopropanol).  Concentration of plasmid DNA 
is measured by spectrophotometry.
 After digesting EGFP-LC3 from pEGFP-LC3m and double digesting pRP 
backbone with Age1 followed by Not1, products were gel purified using a 1% 
agarose gel for one hour, 83 V.  To test proper insertion of EGFP-LC3 into pRP 
(pRP::EGFP-LC3), 10µL of miniprepped DNA was test digested with EcoR1 
followed by gel electrophoresis of total test digest reaction onto a 1% agarose 
gel.  All agarose gels contained 0.5µg/mL ethidium bromide (EtBr), which 
fluoresces under UV light when intercalated into the major groove of DNA.  Gel 
images were taken on a BioRad Gel Doc 1000 and image was printed on a 
Kodak XL 7700 dye sublimation printer.
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CHAPTER 4: Discussion
Co-Culture Effectors
 The mode of M.tb-infected macrophages cell death plays a large role in 
determining whether M.tb survives or is killed by its host [159].  The work 
described in Chapter 2 examines the how interactions between naïve 
macrophages added to M.tb-infected macrophages in co-culture changes the 
outcome pre-determined by whether the infected macrophage undergoes 
apoptosis or necrosis after infection, which was previously identified by Lee et. al. 
[2].  
 In our pursuit to understand how these two populations of macrophages 
communicate to reduce viability of M.tb in a heavily infected, apoptotic 
macrophage, we quickly identified inducible host enzyme NOS2, but not 
GPphox91, as a key player in the co-culture antimycobacterial effect.  After 
identifying the involvement of NOS2 in our system, we moved on to look for 
molecules and other cell processes that could be acting to stimulate NOS2.  We 
did not consider that the addition of naive macrophages to infected ones could 
possibly be enhancing NOS2 effects.  Furthermore, we did not investigate 
whether IL-1β was influencing NOS2 expression in heavily infected cells which 
would be worthwhile investigating as it has been shown to increase iNOS in other 
systems [160, 161].  
 We also determined that IL-1 was a key communicator for these events to 
occur.  An interesting point in regards to IL-1 in the co-culture effect is that though 
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it was critical, it was not functioning in the positive feedback loop typically 
observed for enhanced immune signaling [162].  However this is consistent with 
findings that in IL-1β processing in M.tb-infected macrophages is independent of 
inflammasome activation and also that M.tb is able to reduce IL-1R expression 
on macrophages [53, 162].  Together this suggests an alternative role in IL-1β 
signaling.
 The idea that IL-1β could be inducing signaling molecules not previously 
identified in restricting mycobacterial growth is extremely interesting.  We made 
significant efforts to determine the nature of the molecules involved yet came up 
with nothing.  One possibility that has not been completely eliminated is the 
involvement of eicosanoids as the efferent signal in the co-culture effect.  TLR 4 
signaling can induce the production of COX and 5-LO generation of eicosanoids 
[121].  Since TLR 4 and IL-1R both signal via MyD88 adaptor molecules, as 
previously discussed, it is not out of the question that IL-1 signaling in 
macrophages could induce eicosanoid production as well.  Additionally, virulent 
strains of M.tb are known to inhibit PGE2 production, as a way to favor necrotic 
cell death of its host cell as compared to TNFα-dependent, antimicrobial 
apoptotic cell death [30].  One possible mechanism for the infected macrophages 
enhanced ability to reduce mycobacterial viability in the context of co-culture is 
through production of PGE2 from an uninfected, neighboring cell responding to 
cytokine signals.  In this scenario, the naïve macrophage would be enhancing or 
stimulating the similar antimicrobial mechanisms involved in the TNF-dependent 
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apoptotic cell death killing of M.tb and could be tested with various caspase 
inhibitors.
 Though indomethacin and aspirin experiments suggest that bioactive 
eicosanoid molecules resulting from COX modification of arachidonic acid are not 
involved in the co-culture effect, the effects of indomethacin, but not aspirin, are 
reversible when not kept in culture media.  It is possible that using these drugs to 
test involvement of eicosanoids is not optimal, and it is not out of the question 
given the heat stability and small size of the unknown efferent signal that a lipid 
could be the effecting molecule.  Furthermore, using indomethacin and aspirin as 
drugs to inhibit eicosanoid production in macrophages  is limiting because it does 
not tell us about the involvement of leukotrines such as LTA4, and the products 
resulting from 5-LO activity.  In fact, the testing of products resulting from 5-LO 
activity is almost completely absent in our studies and would be worthwhile 
looking in to especially in light of recent studies by Divangahi et. al. showing the 
important balance between 5-LO and COX products in the immune response to 
M.tb [35].
 We also tested the activity of various commercially available eicosanoids 
on heavily infected cells to assess if they had the potential to be enhancing the 
co-culture antimicrobial effect.  Though we did not observe any reduction in 
mycobacterial growth after treating macrophages with the molecules, it is 
possible that they were not as bioactive as the molecules produced by naïve 
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macrophages.  Given these ideas, it is not out of the question to assume the 
possibility of eicosanoid signaling in the co-culture effect.  
 The supernatants from co-culturing heavily infected cells with naive 
macrophages were thoroughly examined.  The results demonstrated that the 
molecule(s) critically involved in the antibacterial effect were heat stable, smaller 
than 3KDa and resistant to RNase, DNase and Proteinase K treatment.  We 
tested likely candidates that met the qualifications but to no avail.  Though the 
lipid candidates are not totally excluded, other possibilities for the efferent signal 
include heat-stable small molecules, though HPLC analysis for small molecules 
didn’t reveal anything significantly different between infected macrophages and 
co-culture supernatants, it is critical to keep in mind that a broad search for small 
molecules is not the most efficient approach and a more targeted search would 
likely yield better results.
 One possible small molecule that was not examined in the co-culture 
experiments is Vitamin D.  It has been previously reported that M.tb derived 
19KDa lipopeptide increases vitamin D receptor (VDR) expression on 
macrophages in vivo and in vitro [163].  Vitamin D signaling is known to induce 
expression of antimicrobial peptide cathelicidin which in addition to having 
antimicrobial properties is an inducer of autophagy and comes into contact with 
M.tb in phagosomes [86, 164].  Recent studies supported this and further shown 
that vitamin D in its 1,25D3 form, induces cathelicidin-dependent induction of 
autophagy and phagosomal maturation that is able to inhibit mycobacterial 
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growth [165].  These new studies are extremely exciting as they demonstrate that 
the vitamin D3 active metabolite 1α,25-dihydroxycholecalciferol (1,25D3) is 
sufficient to induce autophagy in M.tb infected macrophages.  It is possible that in 
a high MOI model of infection, enough vitamin D is produced to induce 
autophagy in an autocrine fashion through a similar mechanism.  One possible 
mechanism for enhancing vitamin-D dependent inhibition of mycobacterial 
growth is through dual action of 1,25D3 and IL-1β.  There is evidence that these 
two molecules are able to synergize in order to activate TLR2/1 antimicrobial 
pathways for the clearance of M.tb in vitro (Lui 2009).  It is possible that IL-1β 
from our heavily infected macrophages is synergizing with bioactive vitamin D 
from either population of cells to reduce mycobacterial viability in the co-culture 
conditions described in chapter 2.
M.tb-induced autophagy
 One of the most interesting results in this work is that high MOI M.tb 
infection in macrophages induces autophagy in the absence of IFNϒ and that low 
MOI infection of macrophages does not activate autophagy at all even at later 
time points.  Additionally, in most studies looking at the effects of inducing 
autophagy in M.tb-infected cells have demonstrated that autophagy is 
antimycobactericidal.  Data presented in chapter 2 describes a mode of 
autophagy that is not directly microbicidal.  When heavily infected macrophages 
are cultured for 24 hours, autophagy is induced at high levels but the residing 
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bacilli are not growth restricted.  Studies have shown that M.tb can modulate the 
infected macrophage to make IL-6 which reduces the macrophage sensitivity to 
IFNϒ which indicates an indirect mechanism for M.tb to evade autophagic-
induced clearance from the host [166].  
 Given that in our experiments there was no exogenous treatment of the 
infected cells was necessary to induce autophagy, it is unclear what cellular 
signals induced autophagy in the high MOI conditions.  One possible mechanism 
for high MOI-induced autophagy is M.tb-NOD2 stimulation, an idea originally 
posed by Huynh et. al. [162] based on the idea that mycobacteria, contain a N-
glycolyl variant of muranyl dipeptide (MDP), a component of peptidoglycan, 
which activates NOD2 signaling better than the variation found in avirulent strains  
of mycobacteria [167] and is able stimulate autophagy [168].
 What is more interesting to consider is whether or not autophagy plays a 
role in the co-culture antimicrobial effect.  Our data suggests that it is likely that 
M.tb is unable to block progression of its phagosome in the endocytic pathway in 
heavily infected macrophages.  However, this phenomenon is observed without 
the addition of the naïve macrophage population and is not sufficient for killing 
M.tb.  This suggests again, that it would be useful to look for co-culture candidate 
effector molecules, such as cathelicidin, that have both antimicrobial properties 
and have been previously associated with autophagic killing mechanisms.
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Model & Conclusions
 A lucrative model for the possible involvement of IL-1, iNOS, vitamin D and 
autophagy is extremely plausible and illustrated in figure 4.1.  It is possible that 
IL-1β sensing by the naïve macrophage results in stimulating the conversion of 
inactive vitamin D (25D3) to active vitamin D (1,25D3) and is released into the 
supernatant and able to diffuse into the heavily infected macrophages.  From 
there, 1,25D3 can bind to the VDR in the nucleus and affect the transcription of 
genes affected by the vitamin D response element (VDRE).  This activates Beclin 
1 and upregulates autophagy in the infected macrophage in addition to 
generation of anti-microbial peptide cathelicidin.  The M.tb-containing 
autophagosome then fuses with lysosomes resulting in exposing M.tb bacilli to 
lower pH and hydrolytic enzymes.  Both contributing to the ultimate demise of 
intracellular M.tb in the heavily infected macrophage.  However, In addition to 
these mechanisms, NOS2 expression is induced and NO contributes to the 
antimicrobial effect.  This model takes into account the possibility of vitamin D 
signaling affecting the induction of autophagy in M.tb infected macrophages and 
the possible contribution of IL-1β.  
 Overall, this data has broad implications for understanding TB at the early 
stages of granuloma formation and at the point of reactivation.  It is clear from 
studies in our lab that there is unrestricted bacillary growth resulting in heavily 
infected cells in the mouse lung which would increase spreading of M.tb to 
numerous macrophages locally and increase chemokine and cytokine production 
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leading to granuloma formation and as the mechanism a human host uses to 
confine M.tb infection in the lung [108].  In this environment, there are numerous 
interactions of infected macrophages with immune cells that are recruited to the 
infection site.  Examining the co-culture conditions in vitro and figuring out the 
mechanism of cross-talk between naïve and infected macrophages could shed 
light on better ways to treat TB in the future.
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Figure 4.1: Hypothetical model of the high MOI co-culture antimycobactericidal effect.  It is 
possible that IL-1β sensing by the naïve macrophage results in stimulating the conversion of 
inactive vitamin D (25D3) to active vitamin D (1,25D3) and is released into the supernatant and 
able to diffuse into the heavily infected macrophages.  From there, 1,25D3 can bind to the VDR in 
the nucleus and affect the transcription of genes affected by the vitamin D response element 
(VDRE).  This activates Beclin 1 and upregulates autophagy in the infected macrophage in 
addition to generation of anti-microbial peptide cathelicidin.  The M.tb-containing autophagosome 
then fuses with lysosomes resulting in exposing M.tb bacilli to lower pH and hydrolytic enzymes.
99
References
1. Keane, J., H.G. Remold, and H. Kornfeld, Virulent Mycobacterium 
tuberculosis strains evade apoptosis of infected alveolar macrophages. J 
Immunol, 2000. 164(4): p. 2016-20.
2. Lee, J., et al., Macrophage apoptosis in response to high intracellular 
burden of Mycobacterium tuberculosis is mediated by a novel caspase-
independent pathway. J Immunol, 2006. 176(7): p. 4267-74.
3. WHO Report 2011: Global Tuberculosis Control, 2011, World Health 
Organization: Geneva.
4. Organization, W.H., WHO Global Task Force outlines measures to combat 
XDR-TB worldwide, in WHO Media Centre Notes for the Media2006, 
World Health Organization: Geneva.
5. Ulrichs, T. and S.H. Kaufmann, New insights into the function of 
granulomas in human tuberculosis. The Journal of pathology, 2006. 208
(2): p. 261-9.
6. Russell, D.G., Who puts the tubercle in tuberculosis? Nature reviews. 
Microbiology, 2007. 5(1): p. 39-47.
7. Vandiviere, H.M., et al., The treated pulmonary lesion and its tubercle 
bacillus. II. The death and resurrection. The American journal of the 
medical sciences, 1956. 232(1): p. 30-7; passim.
8. Kaplan, G., et al., Mycobacterium tuberculosis growth at the cavity 
surface: a microenvironment with failed immunity. Infection and immunity, 
2003. 71(12): p. 7099-108.
9. Harisinghani, M.G., et al., Tuberculosis from head to toe. Radiographics : 
a review publication of the Radiological Society of North America, Inc, 
2000. 20(2): p. 449-70; quiz 528-9, 532.
10. Dorhoi, A., S.T. Reece, and S.H. Kaufmann, For better or for worse: the 
immune response against Mycobacterium tuberculosis balances 
pathology and protection. Immunological reviews, 2011. 240(1): p. 235-51.
11. Rustad, T.R., et al., Hypoxia: a window into Mycobacterium tuberculosis 
latency. Cellular microbiology, 2009. 11(8): p. 1151-9.
12. Barry, C.E., 3rd, et al., The spectrum of latent tuberculosis: rethinking the 
biology and intervention strategies. Nature reviews. Microbiology, 2009. 7
(12): p. 845-55.
13. Flynn, J.L., Immunology of tuberculosis and implications in vaccine 
development. Tuberculosis, 2004. 84(1-2): p. 93-101.
14. Ullrich, H.J., W.L. Beatty, and D.G. Russell, Direct delivery of procathepsin 
D to phagosomes: implications for phagosome biogenesis and parasitism 
by Mycobacterium. European journal of cell biology, 1999. 78(10): p. 
739-48.
15. Malik, Z.A., G.M. Denning, and D.J. Kusner, Inhibition of Ca(2+) signaling 
by Mycobacterium tuberculosis is associated with reduced phagosome-
100
lysosome fusion and increased survival within human macrophages. The 
Journal of experimental medicine, 2000. 191(2): p. 287-302.
16. Crowle, A.J., et al., Evidence that vesicles containing living, virulent 
Mycobacterium tuberculosis or Mycobacterium avium in cultured human 
macrophages are not acidic. Infection and immunity, 1991. 59(5): p. 
1823-31.
17. Oh, Y.K. and R.M. Straubinger, Intracellular fate of Mycobacterium avium: 
use of dual-label spectrofluorometry to investigate the influence of 
bacterial viability and opsonization on phagosomal pH and phagosome-
lysosome interaction. Infection and immunity, 1996. 64(1): p. 319-25.
18. Sturgill-Koszycki, S., U.E. Schaible, and D.G. Russell, Mycobacterium-
containing phagosomes are accessible to early endosomes and reflect a 
transitional state in normal phagosome biogenesis. The EMBO journal, 
1996. 15(24): p. 6960-8.
19. Sturgill-Koszycki, S., et al., Lack of acidification in Mycobacterium 
phagosomes produced by exclusion of the vesicular proton-ATPase. 
Science, 1994. 263(5147): p. 678-81.
20. Via, L.E., et al., Arrest of mycobacterial phagosome maturation is caused 
by a block in vesicle fusion between stages controlled by rab5 and rab7. 
The Journal of biological chemistry, 1997. 272(20): p. 13326-31.
21. Clemens, D.L. and M.A. Horwitz, The Mycobacterium tuberculosis 
phagosome interacts with early endosomes and is accessible to 
exogenously administered transferrin. The Journal of experimental 
medicine, 1996. 184(4): p. 1349-55.
22. Clemens, D.L., B.Y. Lee, and M.A. Horwitz, Deviant expression of Rab5 on 
phagosomes containing the intracellular pathogens Mycobacterium 
tuberculosis and Legionella pneumophila is associated with altered 
phagosomal fate. Infection and immunity, 2000. 68(5): p. 2671-84.
23. Vergne, I., et al., Mechanism of phagolysosome biogenesis block by viable 
Mycobacterium tuberculosis. Proceedings of the National Academy of 
Sciences of the United States of America, 2005. 102(11): p. 4033-8.
24. Davis, A.S., et al., Mechanism of inducible nitric oxide synthase exclusion 
from mycobacterial phagosomes. PLoS pathogens, 2007. 3(12): p. e186.
25. Johansen, P., et al., Relief from Zmp1-mediated arrest of phagosome 
maturation is associated with facilitated presentation and enhanced 
immunogenicity of mycobacterial antigens. Clinical and vaccine 
immunology : CVI, 2011. 18(6): p. 907-13.
26. Master, S.S., et al., Mycobacterium tuberculosis prevents inflammasome 
activation. Cell host & microbe, 2008. 3(4): p. 224-32.
27. Harris, J., et al., Autophagy controls IL-1beta secretion by targeting pro-
IL-1beta for degradation. J Biol Chem, 2011. 286(11): p. 9587-97.
101
28. Hartman, M.L. and H. Kornfeld, Interactions between naive and infected 
macrophages reduce Mycobacterium tuberculosis viability. PloS one, 
2011. 6(11): p. e27972.
29. Mahon, R.N., et al., Mycobacterium tuberculosis ManLAM inhibits T-cell-
receptor signaling by interference with ZAP-70, Lck and LAT 
phosphorylation. Cellular immunology, 2012.
30. Divangahi, M., et al., Eicosanoid pathways regulate adaptive immunity to 
Mycobacterium tuberculosis. Nature immunology, 2010. 11(8): p. 751-8.
31. Tobin, D.M., et al., Host genotype-specific therapies can optimize the 
inflammatory response to mycobacterial infections. Cell, 2012. 148(3): p. 
434-46.
32. Chen, M., et al., Lipid mediators in innate immunity against tuberculosis: 
opposing roles of PGE2 and LXA4 in the induction of macrophage death. 
The Journal of experimental medicine, 2008. 205(12): p. 2791-801.
33. Park, J.S., et al., Virulent clinical isolates of Mycobacterium tuberculosis 
grow rapidly and induce cellular necrosis but minimal apoptosis in murine 
macrophages. Journal of leukocyte biology, 2006. 79(1): p. 80-6.
34. Chen, M., H. Gan, and H.G. Remold, A mechanism of virulence: virulent 
Mycobacterium tuberculosis strain H37Rv, but not attenuated H37Ra, 
causes significant mitochondrial inner membrane disruption in 
macrophages leading to necrosis. Journal of immunology, 2006. 176(6): p. 
3707-16.
35. Divangahi, M., et al., Mycobacterium tuberculosis evades macrophage 
defenses by inhibiting plasma membrane repair. Nature immunology, 
2009. 10(8): p. 899-906.
36. Kleinnijenhuis, J., et al., Innate immune recognition of Mycobacterium 
tuberculosis. Clinical & developmental immunology, 2011. 2011: p. 
405310.
37. Bekierkunst, A., et al., Granuloma formation induced in mice by chemically 
defined mycobacterial fractions. Journal of bacteriology, 1969. 100(1): p. 
95-102.
38. Abel, B., et al., Toll-like receptor 4 expression is required to control chronic 
Mycobacterium tuberculosis infection in mice. Journal of immunology, 
2002. 169(6): p. 3155-62.
39. Drennan, M.B., et al., Toll-like receptor 2-deficient mice succumb to 
Mycobacterium tuberculosis infection. The American journal of pathology, 
2004. 164(1): p. 49-57.
40. Reiling, N., et al., Cutting edge: Toll-like receptor (TLR)2- and TLR4-
mediated pathogen recognition in resistance to airborne infection with 
Mycobacterium tuberculosis. Journal of immunology, 2002. 169(7): p. 
3480-4.
41. Sugawara, I., et al., Mycobacterial infection in TLR2 and TLR6 knockout 
mice. Microbiology and immunology, 2003. 47(5): p. 327-36.
102
42. Heldwein, K.A., et al., TLR2 and TLR4 serve distinct roles in the host 
immune response against Mycobacterium bovis BCG. Journal of 
leukocyte biology, 2003. 74(2): p. 277-86.
43. Shim, T.S., O.C. Turner, and I.M. Orme, Toll-like receptor 4 plays no role in 
susceptibility of mice to Mycobacterium tuberculosis infection. 
Tuberculosis, 2003. 83(6): p. 367-71.
44. Shi, S., et al., Expression of many immunologically important genes in 
Mycobacterium tuberculosis-infected macrophages is independent of both 
TLR2 and TLR4 but dependent on IFN-alphabeta receptor and STAT1. 
Journal of immunology, 2005. 175(5): p. 3318-28.
45. Akira, S., Mammalian Toll-like receptors. Current opinion in immunology, 
2003. 15(1): p. 5-11.
46. Fremond, C.M., et al., IL-1 receptor-mediated signal is an essential 
component of MyD88-dependent innate response to Mycobacterium 
tuberculosis infection. Journal of immunology, 2007. 179(2): p. 1178-89.
47. Fremond, C.M., et al., Fatal Mycobacterium tuberculosis infection despite 
adaptive immune response in the absence of MyD88. The Journal of 
clinical investigation, 2004. 114(12): p. 1790-9.
48. Scanga, C.A., et al., MyD88-deficient mice display a profound loss in 
resistance to Mycobacterium tuberculosis associated with partially 
impaired Th1 cytokine and nitric oxide synthase 2 expression. Infection 
and immunity, 2004. 72(4): p. 2400-4.
49. Yamada, H., et al., Protective role of interleukin-1 in mycobacterial 
infection in IL-1 alpha/beta double-knockout mice. Laboratory 
investigation; a journal of technical methods and pathology, 2000. 80(5): p. 
759-67.
50. Juffermans, N.P., et al., Interleukin-1 signaling is essential for host defense 
during murine pulmonary tuberculosis. The Journal of infectious diseases, 
2000. 182(3): p. 902-8.
51. Janeway, C.T., Paul; Walport, Mark; Shlomchik, Mark, Immunobiology: 
The Immune System in Health and Disease. 6 ed2005, New York: Garland 
Science Publishing.
52. Raja, A., Immunology of tuberculosis. The Indian journal of medical 
research, 2004. 120(4): p. 213-32.
53. Mayer-Barber, K.D., et al., Caspase-1 independent IL-1beta production is 
critical for host resistance to mycobacterium tuberculosis and does not 
require TLR signaling in vivo. Journal of immunology, 2010. 184(7): p. 
3326-30.
54. Mayer-Barber, K.D., et al., Innate and adaptive interferons suppress 
IL-1alpha and IL-1beta production by distinct pulmonary myeloid subsets 
during Mycobacterium tuberculosis infection. Immunity, 2011. 35(6): p. 
1023-34.
103
55. Stevenson, F.T., et al., The N-terminal propiece of interleukin 1 alpha is a 
transforming nuclear oncoprotein. Proceedings of the National Academy of 
Sciences of the United States of America, 1997. 94(2): p. 508-13.
56. Dinarello, C.A., Biologic basis for interleukin-1 in disease. Blood, 1996. 87
(6): p. 2095-147.
57. Dinarello, C.A., A clinical perspective of IL-1beta as the gatekeeper of 
inflammation. European journal of immunology, 2011. 41(5): p. 1203-17.
58. Banerjee, M. and M. Saxena, Interleukin-1 (IL-1) family of cytokines: Role 
in Type 2 Diabetes. Clinica chimica acta; international journal of clinical 
chemistry, 2012. 413(15-16): p. 1163-70.
59. Kleinnijenhuis, J., et al., Transcriptional and inflammasome-mediated 
pathways for the induction of IL-1beta production by Mycobacterium 
tuberculosis. European journal of immunology, 2009. 39(7): p. 1914-22.
60. Jun, H.K., et al., Integrin alpha5beta1 Activates the NLRP3 Inflammasome 
by Direct Interaction with a Bacterial Surface Protein. Immunity, 2012.
61. Novikov, A., et al., Mycobacterium tuberculosis Triggers Host Type I IFN 
Signaling To Regulate IL-1{beta} Production in Human Macrophages. 
Journal of immunology, 2011. 187(5): p. 2540-7.
62. Williams, K.I. and G.A. Higgs, Eicosanoids and inflammation. The Journal 
of pathology, 1988. 156(2): p. 101-10.
63. Harizi, H., J.B. Corcuff, and N. Gualde, Arachidonic-acid-derived 
eicosanoids: roles in biology and immunopathology. Trends in molecular 
medicine, 2008. 14(10): p. 461-9.
64. Shinomiya, S., et al., Regulation of TNFalpha and interleukin-10 
production by prostaglandins I(2) and E(2): studies with prostaglandin 
receptor-deficient mice and prostaglandin E-receptor subtype-selective 
synthetic agonists. Biochemical pharmacology, 2001. 61(9): p. 1153-60.
65. Stafford, J.B. and L.J. Marnett, Prostaglandin E2 inhibits tumor necrosis 
factor-alpha RNA through PKA type I. Biochemical and biophysical 
research communications, 2008. 366(1): p. 104-9.
66. Glatman-Freedman, A., The role of antibody-mediated immunity in 
defense against Mycobacterium tuberculosis: advances toward a novel 
vaccine strategy. Tuberculosis, 2006. 86(3-4): p. 191-7.
67. Boom, W.H., et al., Human immunity to M. tuberculosis: T cell subsets and 
antigen processing. Tuberculosis, 2003. 83(1-3): p. 98-106.
68. Winau, F., S.H. Kaufmann, and U.E. Schaible, Apoptosis paves the detour 
path for CD8 T cell activation against intracellular bacteria. Cellular 
microbiology, 2004. 6(7): p. 599-607.
69. Chen, C.Y., et al., A critical role for CD8 T cells in a nonhuman primate 
model of tuberculosis. PLoS pathogens, 2009. 5(4): p. e1000392.
70. Randhawa, P.S., Lymphocyte subsets in granulomas of human 
tuberculosis: an in situ immunofluorescence study using monoclonal 
antibodies. Pathology, 1990. 22(3): p. 153-5.
104
71. Tufariello, J.M., J. Chan, and J.L. Flynn, Latent tuberculosis: mechanisms 
of host and bacillus that contribute to persistent infection. The Lancet 
infectious diseases, 2003. 3(9): p. 578-90.
72. Flynn, J.L. and J.D. Ernst, Immune responses in tuberculosis. Current 
opinion in immunology, 2000. 12(4): p. 432-6.
73. Poquet, Y., et al., Human gamma delta T cells in tuberculosis. Research in 
immunology, 1996. 147(8-9): p. 542-9.
74. Szereday, L., Z. Baliko, and J. Szekeres-Bartho, The role of Vdelta2+T-
cells in patients with active Mycobacterium tuberculosis infection and 
tuberculin anergy. The international journal of tuberculosis and lung 
disease : the official journal of the International Union against Tuberculosis  
and Lung Disease, 2008. 12(3): p. 262-8.
75. Meraviglia, S., et al., gammadelta T cells cross-link innate and adaptive 
immunity in Mycobacterium tuberculosis infection. Clinical & 
developmental immunology, 2011. 2011: p. 587315.
76. Chen, Z.W. and N.L. Letvin, Adaptive immune response of 
Vgamma2Vdelta2 T cells: a new paradigm. Trends in immunology, 2003. 
24(4): p. 213-9.
77. Fournie, J.J. and M. Bonneville, Stimulation of gamma delta T cells by 
phosphoantigens. Research in immunology, 1996. 147(5): p. 338-47.
78. Huang, D., et al., Immune distribution and localization of phosphoantigen-
specific Vgamma2Vdelta2 T cells in lymphoid and nonlymphoid tissues in 
Mycobacterium tuberculosis infection. Infection and immunity, 2008. 76(1): 
p. 426-36.
79. Tanaka, Y., et al., Nonpeptide ligands for human gamma delta T cells. 
Proceedings of the National Academy of Sciences of the United States of 
America, 1994. 91(17): p. 8175-9.
80. Kabelitz, D., et al., The primary response of human gamma/delta + T cells 
to Mycobacterium tuberculosis is restricted to V gamma 9-bearing cells. 
The Journal of experimental medicine, 1991. 173(6): p. 1331-8.
81. Boom, W.H., et al., Role of the mononuclear phagocyte as an antigen-
presenting cell for human gamma delta T cells activated by live 
Mycobacterium tuberculosis. Infection and immunity, 1992. 60(9): p. 
3480-8.
82. Pietschmann, K., et al., Toll-like receptor expression and function in 
subsets of human gammadelta T lymphocytes. Scandinavian journal of 
immunology, 2009. 70(3): p. 245-55.
83. Wesch, D., et al., Direct costimulatory effect of TLR3 ligand poly(I:C) on 
human gamma delta T lymphocytes. Journal of immunology, 2006. 176(3): 
p. 1348-54.
84. Kunzmann, V., et al., Polyinosinic-polycytidylic acid-mediated stimulation 
of human gammadelta T cells via CD11c dendritic cell-derived type I 
interferons. Immunology, 2004. 112(3): p. 369-77.
105
85. Casetti, R. and A. Martino, The plasticity of gamma delta T cells: innate 
immunity, antigen presentation and new immunotherapy. Cellular & 
molecular immunology, 2008. 5(3): p. 161-70.
86. Ni Cheallaigh, C., et al., Autophagy in the immune response to 
tuberculosis: clinical perspectives. Clinical and experimental immunology, 
2011. 164(3): p. 291-300.
87. Dunn, W.A., Jr., Studies on the mechanisms of autophagy: formation of 
the autophagic vacuole. The Journal of cell biology, 1990. 110(6): p. 
1923-33.
88. Harris, J., Autophagy and cytokines. Cytokine, 2011. 56(2): p. 140-4.
89. van der Vaart, A., J. Griffith, and F. Reggiori, Exit from the Golgi is required 
for the expansion of the autophagosomal phagophore in yeast 
Saccharomyces cerevisiae. Molecular biology of the cell, 2010. 21(13): p. 
2270-84.
90. Yen, W.L., et al., The conserved oligomeric Golgi complex is involved in 
double-membrane vesicle formation during autophagy. The Journal of cell 
biology, 2010. 188(1): p. 101-14.
91. Yla-Anttila, P., et al., 3D tomography reveals connections between the 
phagophore and endoplasmic reticulum. Autophagy, 2009. 5(8): p. 1180-5.
92. Hailey, D.W., et al., Mitochondria supply membranes for autophagosome 
biogenesis during starvation. Cell, 2010. 141(4): p. 656-67.
93. Ravikumar, B., et al., Regulation of mammalian autophagy in physiology 
and pathophysiology. Physiological reviews, 2010. 90(4): p. 1383-435.
94. Moreau, K., et al., Autophagosome precursor maturation requires 
homotypic fusion. Cell, 2011. 146(2): p. 303-17.
95. Hayashi-Nishino, M., et al., A subdomain of the endoplasmic reticulum 
forms a cradle for autophagosome formation. Nature cell biology, 2009. 11
(12): p. 1433-7.
96. Jagannath, C., et al., Autophagy enhances the efficacy of BCG vaccine by 
increasing peptide presentation in mouse dendritic cells. Nature medicine, 
2009. 15(3): p. 267-76.
97. Harris, J., et al., Th1-Th2 polarisation and autophagy in the control of 
intracellular mycobacteria by macrophages. Veterinary immunology and 
immunopathology, 2009. 128(1-3): p. 37-43.
98. MacMicking, J.D., G.A. Taylor, and J.D. McKinney, Immune control of 
tuberculosis by IFN-gamma-inducible LRG-47. Science, 2003. 302(5645): 
p. 654-9.
99. Gutierrez, M.G., et al., Autophagy is a defense mechanism inhibiting BCG 
and Mycobacterium tuberculosis survival in infected macrophages. Cell, 
2004. 119(6): p. 753-66.
100. Jo, E.K., Innate immunity to mycobacteria: vitamin D and autophagy. 
Cellular microbiology, 2010. 12(8): p. 1026-35.
106
101. Singh, S.B., et al., Human IRGM induces autophagy to eliminate 
intracellular mycobacteria. Science, 2006. 313(5792): p. 1438-41.
102. Harris, J., et al., T helper 2 cytokines inhibit autophagic control of 
intracellular Mycobacterium tuberculosis. Immunity, 2007. 27(3): p. 
505-17.
103. Harris, J., J.C. Hope, and J. Keane, Tumor necrosis factor blockers 
influence macrophage responses to Mycobacterium tuberculosis. The 
Journal of infectious diseases, 2008. 198(12): p. 1842-50.
104. Harris, J. and J. Keane, How tumour necrosis factor blockers interfere with 
tuberculosis immunity. Clinical and experimental immunology, 2010. 161
(1): p. 1-9.
105. Fratazzi, C., et al., Macrophage apoptosis in mycobacterial infections. J 
Leukoc Biol, 1999. 66(5): p. 763-4.
106. Keane, J., B. Shurtleff, and H. Kornfeld, TNF-dependent BALB/c murine 
macrophage apoptosis following Mycobacterium tuberculosis infection 
inhibits bacillary growth in an IFN-gamma independent manner. 
Tuberculosis (Edinb), 2002. 82(2-3): p. 55-61.
107. Barber, G.N., Host defense, viruses and apoptosis. Cell death and 
differentiation, 2001. 8(2): p. 113-26.
108. Vallerskog, T., G.W. Martens, and H. Kornfeld, Diabetic mice display a 
delayed adaptive immune response to Mycobacterium tuberculosis. 
Journal of immunology, 2010. 184(11): p. 6275-82.
109. Keane, J., et al., Infection by Mycobacterium tuberculosis promotes 
human alveolar macrophage apoptosis. Infect Immun, 1997. 65(1): p. 
298-304.
110. Henson, P.M., The immunologic release of constituents from neutrophil 
leukocytes. II. Mechanisms of release during phagocytosis, and 
adherence to nonphagocytosable surfaces. Journal of immunology, 1971. 
107(6): p. 1547-57.
111. Pelegrin, P., C. Barroso-Gutierrez, and A. Surprenant, P2X7 receptor 
differentially couples to distinct release pathways for IL-1beta in mouse 
macrophage. Journal of immunology, 2008. 180(11): p. 7147-57.
112. Ghiringhelli, F., et al., Activation of the NLRP3 inflammasome in dendritic 
cells induces IL-1beta-dependent adaptive immunity against tumors. 
Nature medicine, 2009. 15(10): p. 1170-8.
113. Cruz, C.M., et al., ATP activates a reactive oxygen species-dependent 
oxidative stress response and secretion of proinflammatory cytokines in 
macrophages. The Journal of biological chemistry, 2007. 282(5): p. 
2871-9.
114. Franchi, L., et al., Differential requirement of P2X7 receptor and 
intracellular K+ for caspase-1 activation induced by intracellular and 
extracellular bacteria. The Journal of biological chemistry, 2007. 282(26): 
p. 18810-8.
107
115. Qu, Y., et al., Nonclassical IL-1 beta secretion stimulated by P2X7 
receptors is dependent on inflammasome activation and correlated with 
exosome release in murine macrophages. Journal of immunology, 2007. 
179(3): p. 1913-25.
116. Mortaz, E., et al., ATP and the pathogenesis of COPD. European journal 
of pharmacology, 2010. 638(1-3): p. 1-4.
117. Biswas, D., et al., ATP-induced autophagy is associated with rapid killing 
of intracellular mycobacteria within human monocytes/macrophages. BMC 
immunology, 2008. 9: p. 35.
118. Lammas, D.A., et al., ATP-induced killing of mycobacteria by human 
macrophages is mediated by purinergic P2Z(P2X7) receptors. Immunity, 
1997. 7(3): p. 433-44.
119. Morello, S., et al., IL-1 beta and TNF-alpha regulation of the adenosine 
receptor (A2A) expression: differential requirement for NF-kappa B binding 
to the proximal promoter. Journal of immunology, 2006. 177(10): p. 
7173-83.
120. Buczynski, M.W., D.S. Dumlao, and E.A. Dennis, Thematic Review Series: 
Proteomics. An integrated omics analysis of eicosanoid biology. Journal of 
lipid research, 2009. 50(6): p. 1015-38.
121. Buczynski, M.W., et al., TLR-4 and sustained calcium agonists 
synergistically produce eicosanoids independent of protein synthesis in 
RAW264.7 cells. The Journal of biological chemistry, 2007. 282(31): p. 
22834-47.
122. MacMicking, J.D., et al., Identification of nitric oxide synthase as a 
protective locus against tuberculosis. Proceedings of the National 
Academy of Sciences of the United States of America, 1997. 94(10): p. 
5243-8.
123. Flesch, I.E. and S.H. Kaufmann, Mechanisms involved in mycobacterial 
growth inhibition by gamma interferon-activated bone marrow 
macrophages: role of reactive nitrogen intermediates. Infection and 
immunity, 1991. 59(9): p. 3213-8.
124. Herbst, S., U.E. Schaible, and B.E. Schneider, Interferon gamma activated 
macrophages kill mycobacteria by nitric oxide induced apoptosis. PloS 
one, 2011. 6(5): p. e19105.
125. Nozaki, Y., et al., Mechanism of nitric oxide-dependent killing of 
Mycobacterium bovis BCG in human alveolar macrophages. Infection and 
immunity, 1997. 65(9): p. 3644-7.
126. Vergne, I., et al., Autophagy in immune defense against Mycobacterium 
tuberculosis. Autophagy, 2006. 2(3): p. 175-8.
127. Lee, J., et al., Mycobacterium tuberculosis induces an atypical cell death 
mode to escape from infected macrophages. PloS one, 2011. 6(3): p. 
e18367.
108
128. Panchuk-Voloshina, N., et al., Alexa dyes, a series of new fluorescent 
dyes that yield exceptionally bright, photostable conjugates. The journal of 
histochemistry and cytochemistry : official journal of the Histochemistry 
Society, 1999. 47(9): p. 1179-88.
129. Komatsu, M., et al., Impairment of starvation-induced and constitutive 
autophagy in Atg7-deficient mice. The Journal of cell biology, 2005. 169
(3): p. 425-34.
130. Lee, J., M. Hartman, and H. Kornfeld, Macrophage apoptosis in 
tuberculosis. Yonsei medical journal, 2009. 50(1): p. 1-11.
131. Davis, J.M. and L. Ramakrishnan, The role of the granuloma in expansion 
and dissemination of early tuberculous infection. Cell, 2009. 136(1): p. 
37-49.
132. Giacomini, E., et al., Infection of human macrophages and dendritic cells 
with Mycobacterium tuberculosis induces a differential cytokine gene 
expression that modulates T cell response. Journal of immunology, 2001. 
166(12): p. 7033-41.
133. Sawant, K.V., et al., Guinea pig neutrophil-macrophage interactions during 
infection with Mycobacterium tuberculosis. Microbes and infection / Institut 
Pasteur, 2010. 12(11): p. 828-37.
134. Placido, R., et al., P2X(7) purinergic receptors and extracellular ATP 
mediate apoptosis of human monocytes/macrophages infected with 
Mycobacterium tuberculosis reducing the intracellular bacterial viability. 
Cellular immunology, 2006. 244(1): p. 10-8.
135. Armstrong, J.A. and P.D. Hart, Phagosome-lysosome interactions in 
cultured macrophages infected with virulent tubercle bacilli. Reversal of 
the usual nonfusion pattern and observations on bacterial survival. The 
Journal of experimental medicine, 1975. 142(1): p. 1-16.
136. Miller, B.H., et al., Mycobacteria inhibit nitric oxide synthase recruitment to 
phagosomes during macrophage infection. Infection and immunity, 2004. 
72(5): p. 2872-8.
137. Levine, B. and V. Deretic, Unveiling the roles of autophagy in innate and 
adaptive immunity. Nature reviews. Immunology, 2007. 7(10): p. 767-77.
138. Delgado, M.A., et al., Toll-like receptors control autophagy. The EMBO 
journal, 2008. 27(7): p. 1110-21.
139. Ponpuak, M., et al., Delivery of cytosolic components by autophagic 
adaptor protein p62 endows autophagosomes with unique antimicrobial 
properties. Immunity, 2010. 32(3): p. 329-41.
140. Roberson, S.M. and W.S. Walker, Immortalization of cloned mouse splenic 
macrophages with a retrovirus containing the v-raf/mil and v-myc 
oncogenes. Cellular immunology, 1988. 116(2): p. 341-51.
141. Hornung, V., et al., Silica crystals and aluminum salts activate the NALP3 
inflammasome through phagosomal destabilization. Nature immunology, 
2008. 9(8): p. 847-56.
109
142. Kabeya, Y., et al., LC3, a mammalian homologue of yeast Apg8p, is 
localized in autophagosome membranes after processing. The EMBO 
journal, 2000. 19(21): p. 5720-8.
143. Amano, A., I. Nakagawa, and T. Yoshimori, Autophagy in innate immunity 
against intracellular bacteria. Journal of biochemistry, 2006. 140(2): p. 
161-6.
144. Ling, Y.M., et al., Vacuolar and plasma membrane stripping and 
autophagic elimination of Toxoplasma gondii in primed effector 
macrophages. The Journal of experimental medicine, 2006. 203(9): p. 
2063-71.
145. Andrade, R.M., et al., CD40 induces macrophage anti-Toxoplasma gondii 
activity by triggering autophagy-dependent fusion of pathogen-containing 
vacuoles and lysosomes. The Journal of clinical investigation, 2006. 116
(9): p. 2366-77.
146. Deretic, V., Autophagy as an immune defense mechanism. Current 
opinion in immunology, 2006. 18(4): p. 375-82.
147. Wang, Y., L.M. Weiss, and A. Orlofsky, Host cell autophagy is induced by 
Toxoplasma gondii and contributes to parasite growth. The Journal of 
biological chemistry, 2009. 284(3): p. 1694-701.
148. Vergne, I., et al., Cell biology of mycobacterium tuberculosis phagosome. 
Annual review of cell and developmental biology, 2004. 20: p. 367-94.
149. Russell, D.G., Mycobacterium tuberculosis: here today, and here 
tomorrow. Nature reviews. Molecular cell biology, 2001. 2(8): p. 569-77.
150. Armstrong, J.A. and P.D. Hart, Response of cultured macrophages to 
Mycobacterium tuberculosis, with observations on fusion of lysosomes 
with phagosomes. The Journal of experimental medicine, 1971. 134(3 Pt 
1): p. 713-40.
151. Cherra, S.J., 3rd, R.K. Dagda, and C.T. Chu, Review: autophagy and 
neurodegeneration: survival at a cost? Neuropathology and applied 
neurobiology, 2010. 36(2): p. 125-32.
152. He, C. and D.J. Klionsky, Regulation mechanisms and signaling pathways 
of autophagy. Annual review of genetics, 2009. 43: p. 67-93.
153. Kirisako, T., et al., Formation process of autophagosome is traced with 
Apg8/Aut7p in yeast. The Journal of cell biology, 1999. 147(2): p. 435-46.
154. Cherra, S.J., 3rd, et al., Regulation of the autophagy protein LC3 by 
phosphorylation. The Journal of cell biology, 2010. 190(4): p. 533-9.
155. Pankiv, S., et al., p62/SQSTM1 binds directly to Atg8/LC3 to facilitate 
degradation of ubiquitinated protein aggregates by autophagy. The Journal 
of biological chemistry, 2007. 282(33): p. 24131-45.
156. Van De Parre, T.J., et al., mRNA but not plasmid DNA is efficiently 
transfected in murine J774A.1 macrophages. Biochemical and biophysical 
research communications, 2005. 327(1): p. 356-60.
110
157. Xu, Y., et al., Toll-like receptor 4 is a sensor for autophagy associated with 
innate immunity. Immunity, 2007. 27(1): p. 135-44.
158. Kuma, A. and N. Mizushima, Physiological role of autophagy as an 
intracellular recycling system: with an emphasis on nutrient metabolism. 
Seminars in cell & developmental biology, 2010. 21(7): p. 683-90.
159. Behar, S.M., M. Divangahi, and H.G. Remold, Evasion of innate immunity 
by Mycobacterium tuberculosis: is death an exit strategy? Nature reviews. 
Microbiology, 2010. 8(9): p. 668-74.
160. Campo, G.M., et al., Hyaluronan in part mediates IL-1beta-induced 
inflammation in mouse chondrocytes by up-regulating CD44 receptors. 
Gene, 2012. 494(1): p. 24-35.
161. Sun, H., et al., Nitric oxide-dependent CYP2B1 degradation is potentiated 
by a cytokine-regulated pathway and utilizes the immunoproteasome 
subunit LMP2. The Biochemical journal, 2012.
162. Huynh, K.K., S.A. Joshi, and E.J. Brown, A delicate dance: host response 
to mycobacteria. Current opinion in immunology, 2011. 23(4): p. 464-72.
163. Sonawane, A., et al., Cathelicidin is involved in the intracellular killing of 
mycobacteria in macrophages. Cellular microbiology, 2011.
164. Yuk, J.M., et al., Vitamin D3 induces autophagy in human monocytes/
macrophages via cathelicidin. Cell host & microbe, 2009. 6(3): p. 231-43.
165. Campbell, G.R. and S.A. Spector, Vitamin D Inhibits Human 
Immunodeficiency Virus Type 1 and Mycobacterium tuberculosis Infection 
in Macrophages through the Induction of Autophagy. PLoS pathogens, 
2012. 8(5): p. e1002689.
166. Flynn, J.L., et al., An essential role for interferon gamma in resistance to 
Mycobacterium tuberculosis infection. The Journal of experimental 
medicine, 1993. 178(6): p. 2249-54.
167. Coulombe, F., et al., Increased NOD2-mediated recognition of N-glycolyl 
muramyl dipeptide. The Journal of experimental medicine, 2009. 206(8): p. 
1709-16.
168. Shaw, M.H., et al., The ever-expanding function of NOD2: autophagy, viral 
recognition, and T cell activation. Trends in immunology, 2011. 32(2): p. 
73-9.
111
